TW399053B - Acrylamide derivatives and process for the preparation - Google Patents

Acrylamide derivatives and process for the preparation Download PDF

Info

Publication number
TW399053B
TW399053B TW085100362A TW85100362A TW399053B TW 399053 B TW399053 B TW 399053B TW 085100362 A TW085100362 A TW 085100362A TW 85100362 A TW85100362 A TW 85100362A TW 399053 B TW399053 B TW 399053B
Authority
TW
Taiwan
Prior art keywords
ring
branched
page
printed
cns
Prior art date
Application number
TW085100362A
Other languages
Chinese (zh)
Inventor
Yasumichi Fukuda
Shigeki Seto
Yasuo Oomori
Hiroyuki Ebisu
Shiro Terajima
Original Assignee
Kyorin Seiyaku Kk
Zh Sagami Chuo Kagaku Kenkyojy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk, Zh Sagami Chuo Kagaku Kenkyojy filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of TW399053B publication Critical patent/TW399053B/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Acrylamide derivatives represented by the general formula (1) formula (1) ((S, S)-3, 3'-[3, 3'-1, 4-phenylenediacryloyl]bis-[1-chloromethyl-5-hydroxy-7-trifluoromethyl-1, 2, 3, 6-tetrahydropyrrolo[3, 2-e] indole-8-carboxylic acid methyl ester is a concrete example for the general formula (1)). Acrylamide derivatives represented by the general formula (1) exhibit excellent antineoplastic effects against solid tumor and further has high selectivity to cancer cells with low toxicity.

Description

經濟部中央標準局員工消費合作社印製 A7 B7 ___________-________---—--- 五·、發明第明(I ) [發明之詳細說明] [發明所麕之技術領域] 本發明係關於具有抗腫瘤活性之新穎丙烯醸胺衍生物 ’其光學活性,體及其藥理上容許鹽。 [先前之技術]' ' 具有抗菌活性、抗腫瘤活性之抗生素cc_1065為掲示於 「抗生素期刊(J. Antibiotics)」31 卷,1211 頁(1978年) 、同34卷,1119頁(1981年)、USP 4169888號中,又具有 類似構造之杜歐卡如徽素A(du〇caimycin A)及其類似體為 掲示於W0 87/06255號、EP 0318 05 6號、「抗生素期刊( J.Antibiotics)」42卷,1229頁(1989年)、特_平4-99774 號中。 更且CC-1065之衍生物為揭示於EP 0359454號、特開昭 60-193989號、特表平2-502005號中’又杜歐卡如徽素類 之衍生物為揭示於特開平3-7287號、特開平3-128379號、 EP 0354583號、EP 0406749號中。此些均Μ天然物之基本 骨架原樣供使用,或由天然物之化學修飾所誘發者。 一種化合物中具有2個四氫吡咯並吲哚骨架之化合物雖 包含在特開昭6〇 — 193989號(ΕΡ 0154445號)及特表平2一 502005號(W08804659號)之專利申請範圍中’但並未具體 記載且未揭示其實施例。又’架橋部分為—Rs_T_RV5(R5’ R's為經锻基所取代之苯基、雜環基、苯掘雜環基等’ T為 胺鑛基、截胺基、鑛氧基、氧鑛基等)所^之化合物為被 含己載於特表平卜50066^1^”0 90027 46號)’且架橋部分為 本紙張尺度適用中國國家標準(CNS ) A4规格(210x297公釐) (請先閲讀背面之注意事項再填寫本頁) 裝!-----訂------汰-- A7 B7 經濟部中央標準局員工消费合作社印製 五、發明綁明 ( 1 ' ;- 0 1 ! | 羰 基 雙 (亞胺基- 1H -Π引口朵一 2- 羰 基 ) 5 ,5 ί 一 [(1, 2-- 氧 基 -1 ,2 1 1 1 -乙烷二基) 二 胺 基 ]雙- 1H -Π弓丨Π朵一 2- 羰 基 之 化 合 物 等 為 Μ 實 X--Ν 1 施 例 揭 示 0 請 閲 1 I | 2個具有7 Ξ:氟甲基- 8 ~ 甲 氧 羰 基 -1 ,2 ,3 ,6 -四氫吡咯並[ 讀 背 1 I I 3 , 2- e]吲 環 且 架 部 分 為 羰 基 雙 (亞胺基- 1H 一 π弓|碟- 2- 之 注 J I 意 1 I 羰 基 )之化合物已為本申請人所揭示(特 開 平 6- 116269 號 )° 事 項 1 I 再 1 | 然 而 如 本 發 明 化 合 物 之 丙 烯 醯 胺 衍 生 物 則 為 先 前 未 知。 填 寫 本 k [發明所欲解決之問題] 頁 、〆 I 癌 之 治 療 法 於 臨 床 上 已 使 用 外 科 切 除 法 Μ X 射 線 等 之 1 1 1 放 射 線 療 法 及 Μ 化 學 療 法 劑 之 藥 物 療 法 等 〇 其 中 以 化 學 1 1 療 法 劑 之 藥 物 療 法 為 對 身 體 各 部 位 廣 泛 癌 和 末 期 癌 之 唯 1 訂 —- 治 療 法 0 本 來 Μ m 認 為 患 者 負 擔 最 少 之 此 種 藥 物 療 法 9 1 | 由 於 實 際 上 具 有 強 的 副 作 用 給 予 患 者 嚴 簠 的 苦 痛 〇 又 > 1 I 現 在 的 化 學 療 法 劑 多 數 對 於 细 胞 增 殖 快 的 白 血 病 顯 示 有 效 1 1 1 性 而 對 增 殖 慢 的 固 體 腫 瘤 有 效 性 低 〇 Κ 此 理 由 依 化 學 1 汰 療 法 劑 之 癌 治 療 並 非 —. 定 要 第 __. 選 擇 性 地 實 施 〇 1 本 發 明 為 根 據 此 類 化 學 療 法 的 規. 狀 Μ 提 供 對 癌 细 胞 選 1 擇 性 高 且 對 固 體 腫 瘤 亦 有 效 而 且 為 低 毒 性 之 化 合 物 為 目 的。 1 1 [解決問題之手段] 1 1 本 發 明 者 等 人 為 解 決 上 述 問 題 致 力 研 究 結 果 發 現 新 1 1 穎 之 本 發 明 化 合 物 為 對 癌 细 胞 選 擇 性 髙 1 且 Μ 低 毒 性 對 1 1 固 體 腫 瘤 亦 具 有 強 的 活 性 而 完 成 發 明 〇 I I 即 本 發 明 為 提 供 下 式 (1)所示之丙烯醯胺衍生物 其 1 1 | 光 學 活 性 體 和 其 藥 理 容 許 鹽 及 其 製 造 方 法 0 1 1 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) 五、發明就明(:」 〇 X1 X2 0 (1) A7 B7 (式中,X1及X2為彼此獨立為氫原子、鹵原子、胺基、 烷胺基、胺烷基、羥基、OR3 (R3為直鏈或分支狀“-% 烷基,或可經取代之芳基),OCOR3 (R3為同前述),或直 鐽或分支狀Ci-Ce低烷基。X1及X2亦可彼此結合。環A為 咁咯環、咲喃環、噻吩瑣、笨環、咁啶環、嗒畊環、嘧啶 瑁、六氫吡畊瑁、聯苯基環、二吡啶瓖、二嘧啶環、萘環 、憩環、或唇醌環。R1及R2彼此獨立為Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 ___________-________ --- --- --- 5th, invention (I) [Detailed description of the invention] [Technical field of the invention] The present invention relates to Antitumor activity of the novel acrylamide derivative 'its optical activity, and its pharmacologically acceptable salts. [Previous technology] '' Antibiotic cc_1065 with antibacterial and antitumor activity is shown in "J. Antibiotics" Volume 31, page 1211 (1978), same volume 34, page 1119 (1981), In USP 4169888, duocaimycin A and its analogs with similar structures are shown in WO 87/06255, EP 0318 05 6, and "J. Antibiotics" "Vol. 42, p. 1229 (1989), No. 4-99774. Moreover, the derivatives of CC-1065 are disclosed in EP 0359454, Japanese Patent Application Publication No. 60-193989, and Japanese Patent Application Publication No. 2-502005. No. 7287, Japanese Patent Application No. 3-128379, EP 0354583, EP 0406749. The basic framework of these natural products is used as it is, or induced by chemical modification of natural products. Although a compound having two tetrahydropyrroloindole skeletons in one kind of compound is included in the scope of patent applications of JP-A-Sho 60-193989 (EP 0154445) and JP-A No. 2-502005 (W08804659), but Examples are not specifically described and disclosed. And the 'bridged part is -Rs_T_RV5 (R5' R's is a phenyl, heterocyclic group, benzene heterocyclic group, etc. substituted by a forging group, etc.'T is an amine group, a tramine group, a oxo group, an oxo group, etc. ) The compound ^ is contained in the special table Pingbu 50066 ^ 1 ^ "0 90027 46") and the bridge part is based on the Chinese paper standard (CNS) A4 size (210x297 mm) (please first Read the notes on the back and fill in this page again) Packing! ----- Order ------ Tip-- A7 B7 Printed by the Consumers 'Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. The invention is bound (1';-0 1! | Carbonylbis (imino- 1H -Π introdo 2-carbonyl) 5, 5 ί mono [(1, 2--oxy-1, 2 1 1 1 -ethanediyl) diamine Group] bis-1H-Π bow 丨 II-carbonyl compound and the like are M and X--N 1 Examples revealed 0 Please read 1 I | 2 have 7 Ξ: fluoromethyl-8 ~ methoxycarbonyl -1, 2, 3, 6 -tetrahydropyrrolo [read back 1 II 3, 2- e] indene ring with carbonyl bis (imino-1H-π bow | dish | disk-2- Note JI means 1 I carbonyl) The compound has been disclosed by the applicant (Japanese Patent Application Laid-Open No. 6-116269) ° Matter 1 I Re 1 | However, the acrylamide derivative of the compound of the present invention is previously unknown. Fill out this k [Problems to be Solved by the Invention] In page 1, the treatment method for cancer of 外科 I has been used clinically by surgical resection M X-ray and other 1 1 1 radiation therapy and M chemotherapeutic drug therapy. Among them, chemical 1 1 Therapeutic drug therapy is the only order for a wide range of cancers and end-stage cancers in various parts of the body --- Therapeutic method 0 This kind of drug therapy that M m thinks has the least burden on patients 9 1 | Due to the strong side effects in patients The pain of this disease is also> 1 I. Many current chemotherapeutic agents show efficacy against leukemia with fast cell proliferation. 1 1 1 Low tumor effectiveness 〇K This reason is not based on chemical treatment of cancer treatment of chemotherapeutic agents.-__. Selective implementation 〇1 The present invention is based on the rules of such chemotherapy. 1 The purpose is to select compounds that are highly selective and effective on solid tumors and that have low toxicity. 1 1 [Means for solving problems] 1 1 The present inventors and others committed to solve the above-mentioned problems and found that new 1 1 The compounds of the present invention are selective for cancer cells and have low toxicity to 1 1 solid tumors. The invention is completed by the activity of Ⅱ. The present invention is to provide the acrylamide derivative represented by the following formula (1): 1 1 | Optically active substance, pharmacologically acceptable salt thereof, and manufacturing method thereof 0 1 1 Standard (CNS) Λ4 specification (210X297 mm) 5. The invention will be clear (:) 〇X1 X2 0 (1) A7 B7 (where X1 and X2 are independently of each other a hydrogen atom, a halogen atom, an amine group, and an alkylamine Group, amine alkyl group, hydroxyl group, OR3 (R3 is a linear or branched "-% alkyl group, or an aryl group which may be substituted), OCOR3 (R3 is the same as above), or straight or branched Ci-Ce is low Alkyl. X1 and X2 can also be combined with each other. Ring A is a pyrrolidine ring, a pyran ring, a thieno ring, a stupid ring, a pyridine ring, a daikon ring, pyrimidine, hexahydropyridine , Biphenyl ring, a pyridine ornamentation, two pyrimidine ring, a naphthalene ring, recreational ring, a quinone ring or lip .R1 and R2 each independently is

----------裝 -------訂-------"線------- (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消费合作社印製 (R4為氫原子,羥基之保護基,或在生體内可分解之取代 基,Y為鹵原子、芳硪醃氧基、低烷硪醢氧基、鹵烷硪醯 氧基、或叠氮基,---------- install ------- order ------- " line ------- (Please read the precautions on the back before filling this page) Economy Printed by the Ministry of Standards and Staff ’s Consumer Cooperatives (R4 is a hydrogen atom, a protective group for a hydroxyl group, or a substituent that can be decomposed in the body, Y is a halogen atom, an aromatic alkoxy group, a lower alkoxy group, Alkoxy, or azide,

:B 為稠環,或 H. H- 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公犛) )或 6 A7 B7 五、發明説明(.}): B is a thick ring, or H. H- The paper size is applicable to the Chinese National Standard (CNS) Λ4 specification (210X297) 牦 or 6 A7 B7 V. Description of the invention (.})

此處,於X1 ,X2所定義之取代基中,所謂的鹵原子為 意指氟原子、氛原子、溴原子、碘原子,且所謂的烷胺基 為意指直鐽或分支狀(^-Cb烷基取代胺基,例如可列舉甲 胺基、二甲胺基、乙胺基、二乙胺基、異丙胺基、二異丙 胺基等。所謂的胺烷基為意指於胺基上结合匚:-%直鐽或 分支狀烷基之胺烷基,且可例示胺甲基,1-胺乙基、2-胺 乙基、1-胺異丙基、2 -胺丙基、3 -胺丙基等。所謂的可經 取代之芳基為意指可經鹵原子、烷基、胺基、烷胺基、胺 烷基、羥基等所取代之芳基,例如可列舉氛笨基、甲笨基 、胺苯基、甲胺笨基、胺甲苯基、羥笨基等 又,所謂的X1及X2為彼此结合倩形為意指,於環A上 為結合K含有縮合伸烷基鏈或1個至2個氧原子,胺基、酯 基、胺甲醯基之伸烷基環的情形,例如可列舉 1-1 - v^n ^^^^1 ml —HI— ml «i mu n nn V~r —m In— mu n^i· t^n (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製Here, in the substituents defined by X1 and X2, the so-called halogen atom means a fluorine atom, an atmospheric atom, a bromine atom, an iodine atom, and the so-called alkylamino group means a straight or branched (^- Examples of the Cb alkyl-substituted amino group include methylamino, dimethylamino, ethylamino, diethylamino, isopropylamino, and diisopropylamino groups. The so-called amine alkyl group refers to an amine group. Bonding amidine:-% amine alkyl of straight or branched alkyl, and exemplified by amine methyl, 1-aminoethyl, 2-amineethyl, 1-amine isopropyl, 2-aminopropyl, 3 -Aminopropyl, etc. The so-called substitutable aryl group means an aryl group which can be substituted by a halogen atom, an alkyl group, an amine group, an alkylamino group, an amine alkyl group, a hydroxyl group, and the like, and examples thereof include arylbenzyl , Methylbenzyl, aminephenyl, methylaminebenzyl, aminetolyl, hydroxybenzyl, etc. Also, the so-called X1 and X2 are bonded to each other, which means that on the ring A, it is bonded to K and contains a condensation alkylene Chain or 1 to 2 oxygen atoms, the case of an alkylene ring of an amine group, an ester group, or a carbamoyl group, for example, 1-1-v ^ n ^^^^ 1 ml —HI— ml «i mu n nn V ~ r —m In— mu n ^ i · t ^ n (Please read the notes on the back before filling out this page) Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

本紙張尺度適用中國國家標率(CNS ) Λ4規格(210X297公釐) 7 A7 B7 五、發明説明(:))This paper size applies to China's National Standards (CNS) Λ4 specification (210X297 mm) 7 A7 B7 V. Description of the invention (:))

HN: 〇 等 所謂(.·Β•几及所示之稿瑁為意指芳香族或非芳番 族之烴類或雜稠環,例如 Μθνλ V-?1" Μθ〇2〇\7,HN: 〇 etc. The so-called (. · Β • Ji and the manuscripts shown) are aromatic or non-aromatic hydrocarbons or heterofused rings, such as Μθνλ V-? 1 " Μθ〇2〇 \ 7,

xs Hxs H

F3Cw、F3Cw,

HH

H 經濟部中央標準局員工消f合作社印製 等之稠環。 又,此處所謂的在生體內可分解之取代基為意指在生體 内分解產生羥基之取代基,例如可列舉烷醢基、烯丙醃基 、低烷氧羰基,取代或未取代之芳氧羰基,可經取代之胺 甲醢基、α-胺基酸醢基殘基等。 低烷醢基之具體例可列舉甲醯基、乙豳基、丙醢基、丁 醃基、三甲基乙醢基、戊醢基、己醢基等,芳醢基之具體 例可列舉午醯基、苯乙醢基、萘醚基等。低垸氧羰基之具 體例可列擧甲氧羰基、乙氧羰基、丙氧羰基、丁氧羰基、 己氧羰基等,所謂的取代或未取代之芳氧羰基可列舉苯氧 羰基、對-氯苯氧羰基、對-甲氧苯氧羰基、對-胺苯氧羰 m^i —^n m· ^^^^1 ^^^^1 «HI —^—vh ^^^^1 In n·^ ^^^^1 f—^ϋ \ y ml n 1^^1- fn nn at*—— (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國阀家標準(('NS ) Λ4規格U10X 297公漦) 8 - 五、發明説明() 基等 羰基 氧羰 苄氧 、 苄 基胺 基 醢 甲 胺 烷 基基 羰 擬 烷烷 或 Λ7 Β7 對 、 基 羰 氧 氮 - 低 對 Η 、 舉 基列 羰可 氣,例 ; 體 氧具 甲的 -基 醯 甲 胺 之 代 取 經 對可 咯 咁 經满部中央標準局貝工消費合作社印製 ----------裝-------訂------成 (請先閱讀背面之注意事項再填寫本頁) 咯 、 的 基代 醯取 甲經 胺可 芳之 Ν-等, 、 基基 基羰簾 醃烷啶 甲咯咐 胺 吡氣 烷::六 低 二 基 胺 甲 基 胺 ra, 二 基 啶 氫 六 - 4 /1, 或 六氫吡啶基)羰基等之可經取代的六氫吡啶羰基、(4-甲基 -1-六氫》比叻基)羰基、[4-[2-(二甲胺基)乙基]-1-六氫啪 哺基]羰基、[4-(2-(羥乙凑)-1-六氫呲哺基]羰基,或 [4-[2-[2-(二甲胺基)乙氧基]乙基]-l-六氫吡畊基]羰基 等之可經取代的卜六氫吡岍羰基,或可經取代之卜嗎福啭 羰基、吡咯烷羰基,或經烷基取代之甲矽烷基等。α-胺 基酸醯基殘基可列舉胺基為經芊氧羰基、芴甲氧羰基或第 三丁氣羰基等保護之甘胺酸、丙胺酸、纈胺酸、白胺酸、 異白胺酸、絲胺酸、蘇胺酸、半胱胺酸、蛋胺酸、天冬胺 酸、麩胺酸、天冬醯胺、麩胺藤胺、雔胺酸、精胺酸、笨 丙胺酸、胳胺酸、組胺酸、色胺酸、脯胺酸及羥基脯胺酸 等之胺基酸醢基殘基。 又,芳磺醯氧基可具體例示苯磺釀氧基、甲笨磺豳氧基 等,低烷磺醯氧基可例示甲烷磺醣氧基、乙烷磺釀氧基、 丙烷磺醯氧基,更且鹵烷硪醯氣基可具體例示三氟甲烷硪 醯氧基、三氯甲烷磺醯氧基等。 [發明之實施型態] 本發明為依Μ下所述之製造方法|提供上式(1)所示之 化合物。 本紙張尺度適用中國國家標準(CNS〉Λ4規格(210><297公篼) -9 — 五、發明锐明(V) A7 B7 即·令下式(2α )所示之羧酸H The staff of the Central Bureau of Standards of the Ministry of Economic Affairs has printed a thick ring of cooperatives and so on. The term “substitutable group decomposable in the living body” herein means a substituent which decomposes in the living body to generate a hydroxyl group. Examples of the substituent include an alkylamino group, an allyl salt, a lower alkoxycarbonyl group, and a substituted or unsubstituted group. Aryloxycarbonyl groups can be substituted aminocarbamyl, α-aminoacid fluorenyl residues, and the like. Specific examples of lower alkylsulfonyl include methylsulfenyl, ethylsulfonyl, propionyl, butanyl, trimethylethylsulfonyl, pentamyl, hexyl, and the like. Specific examples of arylfluorenyl include noon Fluorenyl, phenethylfluorenyl, naphthyl ether and the like. Specific examples of the lower alkoxycarbonyl group include methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl, and hexyloxycarbonyl. Examples of the so-called substituted or unsubstituted aryloxycarbonyl include phenoxycarbonyl and p-chloro. Phenoxycarbonyl, p-methoxyphenoxycarbonyl, p-aminephenoxycarbonyl m ^ i — ^ nm · ^^^^ 1 ^^^^ 1 «HI — ^ — vh ^^^^ 1 In n · ^ ^^^^ 1 f— ^ ϋ \ y ml n 1 ^^ 1- fn nn at * —— (Please read the precautions on the back before filling this page) This paper size is applicable to Chinese valve standards (('NS) Λ4 specification U10X 297 漦) 8-V. Description of the invention () carbonyloxycarbonyl benzyloxy, benzylamino fluorenylmethylamine alkylcarbonylalkane or Λ7 B7 pair, carbonylcarbonyl nitrogen-low pair For example, Gilead can be oxidized, for example; Substitute for body oxygen with methyl-methylmethylamine. Printed on Keluo by the Central Standards Bureau Shellfish Consumer Cooperative. ------- Order ------ Into (please read the precautions on the back before filling this page). Pyrididine Aminopyridine: :: Low Substituted hexahydropyridine carbonyls such as methylamine methylamine ra, diylpyridinium hexa-4 // 1, or hexahydropyridyl) carbonyl, (4-methyl-1-hexahydro "biryl) Carbonyl, [4- [2- (dimethylamino) ethyl] -1-hexahydropyridyl] carbonyl, [4- (2- (hydroxyethoxy) -1-hexahydropyridyl] carbonyl, Or [4- [2- [2- (dimethylamino) ethoxy] ethyl] -l-hexahydropyridyl] carbonyl and the like may be substituted hexahydropyridine carbonyl, or may be substituted Bufo fluorene carbonyl, pyrrolidine carbonyl, silyl substituted by alkyl, etc. Examples of α-amino acid fluorenyl residues are amine oxycarbonyl, fluorenylmethoxycarbonyl, or tertiary butane. Glycine, alanine, valine, leucine, isoleucine, serine, threonine, cysteine, methionine, aspartic acid, glutamic acid, protected by carbonyl groups, etc. Asparagine residues, asparagine, glutamine, ammonium, arginine, stuplanine, tick, histidine, tryptophan, proline and hydroxyproline Specific examples of the arylsulfonyloxy group include benzenesulfonyloxy, methylbenzylsulfonyloxy, and the like. Examples of the group include methanesulfonyloxy group, ethanesulfonyloxy group, and propanesulfonyloxy group, and further examples of the haloalkylfluorenyl group include trifluoromethanesulfonyloxy group, trichloromethanesulfonyloxy group, and the like. [Implementation Mode of the Invention] The present invention is a manufacturing method according to the following method | providing the compound represented by the above formula (1). This paper size is applicable to Chinese national standards (CNS> Λ4 specification (210 > < 297) ) -9 — V. Invent sharp (V) A7 B7 That is, let the carboxylic acid represented by the following formula (2α)

(式中,R5為0Η。環A,X1及X2為同前述。) 與下式(4)或(5)所示之化合物或其鹽(In the formula, R5 is 0Η. Ring A, X1 and X2 are the same as described above.) A compound represented by the following formula (4) or (5) or a salt thereof

經濟部中央標华局員工消費合作社印製 (式中 (·日.([、(C’( 、R4及Υ為同前述。) 使用二瓖己基碳化二亞胺(DCC)或3 -乙基-1-(3 -二甲胺丙 基)碳化二亞胺鹽酸鹽等縮合劑予以縮合,或與(2b)所示 之羧酸的鹵化物,羧酸的眯唑烷基、羧酸的活性酯、羧 酸的混合或對稱酸酐反應 (2b)〇 χ1 V ο (式中,V為鹵原子,1-咪唑基、4-硝苯氧基、琥珀酸亞胺 基氧基等之反應性殘基。) -10 - 本紙張尺度適用中國國家標隼(CNS ) Λ4規格(210Χ297公漦) ----------裝------、1T------^-------- (請先閱讀背面之注意事項再填寫本頁) A7 B7 經濟部中央標隼扃員工消費合作社印製 五、發明説明(Η) 可製造下式(la〉或(lb)所示之化合物Printed by the Employees 'Cooperatives of the Central Standardization Bureau of the Ministry of Economic Affairs (in the formula (· 日. ([, (C' (, R4, and Υ are the same as above).) Use of dihexylcarbodiimide (DCC) or 3-ethyl Condensation agents such as -1- (3-dimethylaminopropyl) carbodiimide hydrochloride, or with halides of carboxylic acids shown in (2b), oxazolidinyl carboxylic acids of carboxylic acids, Mixture of active ester and carboxylic acid or symmetrical anhydride reaction (2b) 0x1 V ο (where V is a halogen atom, reactivity of 1-imidazolyl, 4-nitrophenoxy, succinimidyloxy, etc. Residues.) -10-This paper size is applicable to China National Standard (CNS) Λ4 specification (210 × 297 males) ---------- installation ------, 1T ------ ^ -------- (Please read the notes on the back before filling out this page) A7 B7 Printed by the Central Standards of the Ministry of Economic Affairs and printed by the Employee Consumer Cooperative V. Invention Description (发明) The following formula (la) or (Lb)

(1a) (1b) (式中,環A、 (B反 、::C双 、R4 λ χΐ 、Χ2及Υ為同前 述0 ) 此縮合反應可在三乙胺、二異丙基乙胺、咁啶、二甲胺 基咁啶等之有機鹼、碳酸氫納、碳酸鉀、氫氧化納、氫氧 化鉀等之無機鹼存在下,或非存在下,於二氣甲烷、甲苯 、乙腈、Ν,Ν-二甲基甲醢胺、二甲基亞碼I、四氫呋喃等之 溶劑中,於-20〜50TC下處理30分鐘至48小時而可容易實 胞。 又,下式(lc)所示之化合物(1a) (1b) (wherein ring A, (B trans, :: C bis, R4 λ χ, χ2, and Υ are the same as the foregoing 0). The condensation reaction can be carried out in triethylamine, diisopropylethylamine, Organic bases such as pyridine and dimethylaminopyridine, inorganic bases such as sodium bicarbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, etc., in the presence or absence of dibasic methane, toluene, acetonitrile, Ν , N-dimethylformamide, dimethyl sub code I, tetrahydrofuran and other solvents, can be easily cell-treated at -20 ~ 50TC for 30 minutes to 48 hours. Also, the following formula (lc) Compound

(1c) 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公犛) I-----------裝-------訂------妹--一---. (請先閱讀背面之注意事項再填寫本頁) 11 經滴部中央標準局員工消費合作社印製 A7 B7 五、發明説明(ί)) (式中,瓖A、ί曰j[ ' X1 、X2及Y為同前述。) 經由Μ低烷醢基氯、烯丙醯基氣、低烷氧羰基氣、取代或 未取代之芳氧羰基氛、α-胺基酸氛,可經取代之胺甲醯 基氯,或其活性酯處理,可引導至下式(Id)所示之化合物(1c) The size of this paper is applicable to the Chinese National Standard (CNS) Λ4 specification (210X297) 牦 I ------------------------------- I ---. (Please read the notes on the back before filling out this page) 11 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Labor A7 B7 V. Invention Description (ί)) ['X1, X2 and Y are the same as above.) Via M low alkylfluorenyl chloride, allylsulfonyl gas, low alkoxycarbonyl gas, substituted or unsubstituted aryloxycarbonyl atmosphere, α-amino acid atmosphere, can Treatment with a substituted carbamoyl chloride, or an active ester thereof, can lead to a compound represented by the following formula (Id)

(1d) 此反應可在三乙胺、二異丙基乙胺、咁啶、二甲胺基吡 啶等之有機鹼、碳酸氫納、碳酸鉀等之無機鹼存在下,或 非存在下於惰性溶劑中,M-20〜1001C,較佳為0〜50Ϊ: 實施。 更且,若上式(lc)所示之化合物於鹼存在下進行閉環, 則可引導至上式(1 b )所示之化合物。此反應為將上式(1 c ) 之化合物於1〜10當量奠耳,較佳為1〜5當量其耳之二吖 雙環鹼、三乙胺等之有機鹼,或氳氧化納、氫化納、碳酸 鉀等之無機鹼存在下,於二氯甲烷、甲苯、乙腈、Ν,Ν-二 甲基甲醢胺、二甲基亞颯、四氫呋喃等之惰性溶劑中,或 其混合溶劑中,於-78〜100t:,較佳為0〜50C下經10分 鐘至24小時,較佳為20分鐘至5小時處理而實施。又,上 式(1 b)所示化合物經由在氯化氫、溴化氫、鹽酸、氫漠酸 、甲苯磺酸、苯磺酸、甲烷磺酸、三氟甲烷磺酸、叠氮酸 本纸汴尺度適用中阀内家疗个(CNS ) Λ4规格(210X 297公势) ^1^1 1^1^1 mV 1 —JJ m v^m tl^^i 一aJ— ml Hit - - -- (請先閱讀背面之注意事項再填寫本頁) -12 - 經濟部中央標準局Μ工消费合作社印製 A7 B7 五、發明説明(1 η) 等酸存在下、醋酸乙酯、二氛甲烷、乙腈、Ν,Ν-二甲基甲 醢胺、四氫呋喃等惰性溶劑中,以-20&lt;〇至溶劑沸點之溫 度,較佳為0〜50TC之溫度下處理,可變換成上式(lc)所 示之化合物。於此反應中使用過量酸為使反應時間縮短而 為較佳。 又*下式U) OHC-Vy-CH0 V=&lt; (9) 闩11 (式中,R 11為直鏈或分支狀“-%低烷基。) 及下式(7)所示之二醛衍生物 r12oc-^)-cor,2 0 0, (7) R14 (式中,R 12為OR 13 (R 13為直鐽^?支狀Ci-Ce低烷基),二烷 胺基,R 14為直鏈或分支狀匕-%低烷基,或R14彼此為形 成環之亞甲基、伸乙基、伸丙基。) 可例如依下述方法製造。 本紙張尺度適用个阀罔家樣尊(CNS ) Λ4規格(210X 297公修) ----------E-----1ΪΤ------^ (請先閱讀背面之注意事項再填寫本頁) -13 - 五、發明説明(丨1 ) A7 B7(1d) This reaction can be in the presence of an organic base such as triethylamine, diisopropylethylamine, pyridine, dimethylaminopyridine, etc., an inorganic base such as sodium bicarbonate, potassium carbonate, or in the absence of inert In the solvent, M-20 ~ 1001C, preferably 0 ~ 50Ϊ: Implementation. Furthermore, if the compound represented by the above formula (lc) undergoes ring closure in the presence of a base, it can be led to the compound represented by the above formula (1 b). This reaction is carried out by mixing the compound of the formula (1 c) in 1 to 10 equivalents, preferably 1 to 5 equivalents of an organic base such as diazine, triethylamine, or the like. In the presence of an inorganic base such as potassium carbonate, potassium chloride, etc., in an inert solvent such as dichloromethane, toluene, acetonitrile, Ν, Ν-dimethylformamide, dimethylsulfine, tetrahydrofuran, or a mixed solvent thereof, in -78 ~ 100t :, preferably at 0 ~ 50C, after 10 minutes to 24 hours, preferably 20 minutes to 5 hours. In addition, the compound represented by the above formula (1 b) passes the scale of hydrogen chloride, hydrogen bromide, hydrochloric acid, hydroxamic acid, toluenesulfonic acid, benzenesulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid, and azide. Applicable for domestic valve treatment (CNS) Λ4 specification (210X 297 public potential) ^ 1 ^ 1 1 ^ 1 ^ 1 mV 1 —JJ mv ^ m tl ^^ i aJ— ml Hit---(please first Read the notes on the back and fill in this page) -12-Printed A7 B7 printed by M Industrial Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs 5. Description of the invention (1 η) In the presence of acids such as ethyl acetate, dichloromethane, acetonitrile, Ν , N-dimethylformamide, tetrahydrofuran and other inert solvents, the temperature of -20 <0 to the boiling point of the solvent, preferably 0 to 50 TC, can be converted into the compound represented by the above formula (lc) . The use of excess acid in this reaction is preferred in order to shorten the reaction time. Also, the following formula U) OHC-Vy-CH0 V = &lt; (9) Latch 11 (wherein, R 11 is a linear or branched "-% lower alkyl group." And the two shown by the following formula (7) Aldehyde derivative r12oc-^)-cor, 2 0 0, (7) R14 (wherein R 12 is OR 13 (R 13 is a straight branched Ci-Ce lower alkyl group), a dialkylamino group, R 14 is a linear or branched d-% lower alkyl group, or R 14 is a methylene group, an ethyl group, or a propyl group which form a ring with each other.) It can be manufactured, for example, by the following method. This valve is applicable to a valve. Family Sample Respect (CNS) Λ4 specification (210X 297 public repair) ---------- E ----- 1ΪΤ ------ ^ (Please read the precautions on the back before filling this page ) -13-V. Description of the invention (丨 1) A7 B7

第二製程 A'i-n10 Rl,z,^ i三製程 MeO OMe (4)Second process A'i-n10 Rl, z, ^ i Three processes MeO OMe (4)

第四製程 R10 卩1 V)· (Zz)〇 ,ΆΝ+ rr\ 'N七,〇Fourth process R10 卩 1 V) (Zz) 〇, ΆΝ + rr \ 'N 七, 〇

〇- 第五製程^ 0HC CH0 R^Rn ⑼ (R9為羥基或反應性殘基,Rle為氫原子,直鏈或分支狀 (^-Cb低烷基,R 15為甲基、乙基、苄基、和R11為同前述 經濟部中央標準局員工消费合作社印製 (第一製程) 本製程為,將式(10)所示化合物,Μ式(11)所示化合物 縮合,而製造式(12)所示化合物。 本反應在,R9為0Η之情形中,使用二環己基碳化二亞 胺(DCC)或3-乙基-卜(3-二甲胺丙基)碳化二亞胺鹽酸鹽等 縮合劑予以縮合,或R9為鹵原子等之反應性殘基之情形 中,於吡啶、三乙胺、二異丙基乙胺等鹼存在下,或非存 在下反應而可容易地實施。 (第二製程) 本製程為,式(1 2 )所示化合物經由閉環,而製造下式 (4)所示化合物。本閉環反應為藉由與聚磷酸、聚磷酸酯 -----------裝-------訂------線------- (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國阀家標率(CNS ) Λ4規格(2丨0Χ297公犛) 14 經濟部中央標率局員工消費合作社印製 A7 B7 五、發明説明(丨?) 、硫酸、亞硫酿氛等在0〜100¾下經30分鐘至24小時處理 而可容易地實施。 (第三製程) 本製程為,將式(4)所示化合物經以下式(13)所示之有 機金臑試劑反應 R11 Z1 (13) (式中,Z1 為 Li,MgCil ,MgBr,Ru 為同前述。) 而製造式(5)所示化合物。本反應為藉由在四氫呋喃、乙 醚、二甲氧基乙烷、甲笨、己烷等,或其混合溶劑中進行 ,於-20〜50t:下經30分鐘至24小時處理而可容易地實施。 (第四製程) 本製程為,將式(5)所示化合物經K下式(14)所示化合 物反應 R 15 Z2 (14) (式中,Z 2 為 C 义、B r、I、0 S 0 2 C Η 3, 0S02Me R 15為同前述。) 而製造式(15)所示化合物。本反應為在硝基甲烷、二甲基 甲醚胺、二喟烷等熔劑中,或不使用溶劑而進行,於0〜 1001C下經30分鐘至24小時處理而可容易地實施。 (第五製程) 本製程為藉由將式(15)所示化合物堪原•而製造式(9) 所示之二醛衍生物。本反應中所使用之遒原劑可列舉氫化 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210X297公犛) 裝 , 訂 .^ (請先閱讀背面之注意事項再填寫本頁) -15 - 經濟部中央標準局員工消費合作杜印製 本紙張尺度適用中阀國家標準(CNS ) Λ4規格(210X297公釐) Λ7 B7 五、發明説明(! :j) 二異丁基鋁、氫化鋁鋰、氫化雙(甲氧乙氧基)鋁納,硼氫 化納、氰硼氫化納、硼氫化鋰等。本反應為在甲苯、醚、 四氫呋喃、甲醇、乙酵等,或其混合溶劑中進 行,於-78t:至50TC下圓滑地進行。〇- Fifth process ^ 0HC CH0 R ^ Rn ⑼ (R9 is a hydroxyl or reactive residue, Rle is a hydrogen atom, straight or branched (^ -Cb lower alkyl, R 15 is methyl, ethyl, benzyl The base and R11 are printed with the aforementioned Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (first process). This process is to condense a compound represented by formula (10) and a compound represented by formula (11) to produce formula (12 ). In the case where R9 is 0 碳, this reaction uses dicyclohexylcarbodiimide (DCC) or 3-ethyl-bu (3-dimethylaminepropyl) carbodiimide hydrochloride. In the case where a condensing agent is used to condense or R9 is a reactive residue such as a halogen atom, the reaction can be easily performed in the presence or absence of a base such as pyridine, triethylamine, diisopropylethylamine, or the like. (Second process) In this process, a compound represented by the following formula (4) is produced through ring closure of a compound represented by the formula (1 2). This ring closure reaction is carried out by reacting with polyphosphoric acid and a polyphosphate-- ----- Installation ------- Order ------ Line ------- (Please read the precautions on the back before filling this page) This paper standard is applicable to China valve house standard rate (CNS) Λ4格 (2 丨 0 × 297 公 牦) 14 Printed A7 B7 by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (丨?), Sulfuric acid, sulfurous acid, etc. are processed in 30 minutes to 24 hours at 0 ~ 100¾ It can be easily implemented. (Third process) In this process, a compound represented by the formula (4) is reacted with an organic gold compound represented by the following formula (13) R11 Z1 (13) (wherein Z1 is Li, MgCil, MgBr, Ru are the same as above.) The compound represented by formula (5) is produced. This reaction is carried out in tetrahydrofuran, diethyl ether, dimethoxyethane, methylbenzyl, hexane, or a mixed solvent thereof. At -20 ~ 50t: it can be easily implemented after 30 minutes to 24 hours treatment. (Fourth process) This process is to react a compound represented by formula (5) with a compound represented by formula (14) by R 15 Z2 (14) (wherein Z 2 is C, B r, I, 0 S 0 2 C Η 3, and 0S02Me R 15 is the same as above.) To produce a compound represented by formula (15). This reaction is performed at Nitromethane, dimethyl methyl ether amine, dioxane, or other solvents, or without using a solvent, at 0 to 1001C for 30 minutes to 24 hours (Fifth process) This process is to produce a dialdehyde derivative represented by the formula (9) by converting the compound represented by the formula (15) into an original compound. Korihara used in this reaction Agents can be listed as hydrogenated. The paper size is applicable to Chinese National Standards (CNS) Λ4 specifications (210X297 cm). Order (^ Please read the precautions on the back before filling this page) -15-Staff Consumption of Central Standards Bureau, Ministry of Economic Affairs Cooperate with Du printed the paper standard applicable to the national valve standard (CNS) Λ4 specification (210X297 mm) Λ7 B7 V. Description of the invention (! : j) Diisobutylaluminum, lithium aluminum hydride, sodium bis (methoxyethoxy) aluminum hydride, sodium borohydride, sodium cyanoborohydride, lithium borohydride, etc. This reaction is carried out in toluene, ether, tetrahydrofuran, methanol, acetic acid or the like, or a mixed solvent thereof, and it is smoothly performed at -78t: to 50TC.

r^〇c^\.c〇ri2 R^Z3 (16) ^OC-^-CO^_^OHC-^-CHO HO OH 第六製程 第七製程 $4 (6) (7) (8) (第六製程) 本製程為,將式(6)所示之酚衍生物於碳酸絶存在下, 將下式(丨6 )所示化合物烷基化, R 14 Z3 (16) (式中 * Z3 為 Cl 、Br、I、0S02CH3, 〇S02-&lt;^)~Me R 14為同前述。) 而製造式(7)所示之化合物。本反應為藉由在二甲基甲醢 胺、二甲基乙醜胺、N -甲基吡咯烷睛、二甲基亞礙等之溶 劑中,使用1〜5當量,較佳為2當量之碳酸絶進行,於0〜 100Ό下經30分鐘至24小時處理而可容易地實施。 (第七製程) 本製程為,藉由將式(7)所示化合物堪原而製造式(8 )所 -16 - 1. 111 11¾^ . I 訂 I I I 汰 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消费合作社印製 Λ7 B7 五、發明説明(M ) 示之二醛衍生物。本反應中所使用之遒原劑可列舉氫化二 異丁基鋁、氫化鋁鋰、氫化雙(甲氧乙氧基)鋁鋰、氫化雙 (2-甲氧乙氧基)鋁納/ N-甲基六氫吡哺等。本反應為在甲 苯、醚、IVf私)¾、四氫呋喃等,或其混合溶劑中進行, 於-7 8t:至50¾下圓_地進行。 此處,Rie之直鐽或分支狀(^-(:6低烷基之具體例可列舉 甲基、乙基、丙基、丁基、異丙基等。 R11之直鏈或分支狀(^-(^低烷基之具體例可列舉甲基、 乙基、丙基、丁基、異丙基等。 R13之直鏈或分支狀(:1-(:6低烷基之具體例可列舉甲基、 乙基、丙基、丁基、異丙基等。 二烷胺基之具體例可列舉二甲胺基、二乙胺基、二丁胺 基、二異丙胺基、咁咯烷基、六氫吡啶基等。 R14之直鏈或分支狀(^-(:6低烷基之具體例可列舉甲基、 乙基、丙基、丁基、異丙基等。 本發明之起始物質下式(2a)所示之化合物r ^ 〇c ^ \. c〇ri2 R ^ Z3 (16) ^ OC-^-CO ^ _ ^ OHC-^-CHO HO OH Sixth process Seventh process $ 4 (6) (7) (8) (No. Six processes) In this process, a phenol derivative represented by the formula (6) is alkylated in the presence of carbonic acid, and a compound represented by the following formula (丨 6) is alkylated. R 14 Z3 (16) (where Z Z is Cl, Br, I, OS02CH3, 〇02- &lt; ^) ~ Me R 14 are the same as described above. ) To produce a compound represented by formula (7). This reaction is carried out by using 1 to 5 equivalents, preferably 2 equivalents, in a solvent such as dimethylformamide, dimethylethylamine, N-methylpyrrolidine, dimethylene oxide and the like. Carbonic acid is absolutely carried out, and it can be easily implemented after 30 minutes to 24 hours treatment at 0 to 100 Torr. (Seventh process) This process is to make the compound represented by formula (7) into original formula (8) -16-1. 111 11¾ ^. I order III (Please read the precautions on the back before (Fill in this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Λ7 B7 V. The dialdehyde derivative shown in the description of the invention (M). Examples of rhenium agents used in this reaction include diisobutylaluminum hydride, lithium aluminum hydride, lithium bis (methoxyethoxy) aluminum hydride, and sodium bis (2-methoxyethoxy) aluminum hydride / N- Methylhexahydropyridine and the like. This reaction is carried out in toluene, ether, IVf), tetrahydrofuran, etc., or a mixed solvent thereof, and the reaction is carried out in a round shape at −78 to 50 °. Here, Rie is straight or branched (^-(: 6 specific examples of lower alkyl include methyl, ethyl, propyl, butyl, isopropyl, etc.) R11 is straight or branched (^ -(^ Specific examples of lower alkyl include methyl, ethyl, propyl, butyl, isopropyl, etc .. Linear or branched R13 (: 1-(: 6 specific examples of lower alkyl) Methyl, ethyl, propyl, butyl, isopropyl, and the like. Specific examples of the dialkylamino group include dimethylamino, diethylamino, dibutylamino, diisopropylamino, and pyrrolidinyl. , Hexahydropyridyl and the like. Specific examples of straight or branched R14 (^-(: 6 lower alkyl) include methyl, ethyl, propyl, butyl, isopropyl, etc. The beginning of the present invention A compound represented by the following formula (2a)

(式中,X1 、X2 ,環A及R5為同前述。) 亦為本發明之重要中間產物,可例如依Μ下所述方法製造。 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210Χ297公釐) 批水 1 、一舌^ (請先閱讀背面之注意事項再填寫本頁) -17 - A7 B7 經濟部中央標率局員工消f合作社印製 五、發明説明(li&gt;)(In the formula, X1, X2, and ring A and R5 are the same as described above.) It is also an important intermediate product of the present invention, and can be produced, for example, according to the method described below. This paper size applies to Chinese National Standard (CNS) Λ4 specification (210 × 297 mm). Appropriate water1, one tongue ^ (Please read the notes on the back before filling this page) -17-A7 B7 f. Cooperative print 5. V. Invention Description (li &gt;)

YY

(2〇) (2a) (第八製程) 本製程為,將式(17)所示化合物(式中,Y1為Br、I、 0S02CF3、X1 、X2及瑁A為同前述。)與式(18)所示之丙 烯酸衍生物(式中,R 16為甲氧基、乙氧基、苄氧基、Y2 為氫原子、三甲基甲錫烷基、三丁基甲錫烷基。)於鈀觸 媒下進行緊偶合反應,而製造式(19)所示之二丙烯酸酯衍 生物。本反應可依公知方法(例如「實驗化學講座第4版, 396〜427頁,(1991年),九善」)進行。 (第九製程) 本製程為,將式(19)所示之二丙烯酸酯衍生,物之酯除去 ,而製造式(2a)所示之二丙烯酸衍生物。本反應可依公知 方法(「Protective Groups in Organic Synthese」 ,231 〜2 6 5 頁,(1 9 9 1 年),J 〇 h n W i 1 e y &amp; S u n s )進行。 (第十製程) _本製程為,將式(20)所示之二醛衍生物與丙二酸縮合, 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) I 裝 訂 線 (請先閱讀背面之注意事項再填寫本頁) 一 18 — A7 經濟部中央標準局員工消費合作社印製 B7 ——! 五、發明就明 (Η;) 1 1 1 而 製 造 式 (2 a)所 示之 二 丙烯酸 衍生 物 〇 本 反 懕 可 依 公 知 方 1 1 法 進 行 〇 1 [ 性 體 請 i 上 述 式 (4)及(5)所 示 化合物 之消 旋 體 » 及 其 光 學 活 先 閱 1 | 可 依 公 知 方 法(例如 &quot;T e t r a h e d r ο η L e 11 · J 27卷 4103 頁 a 背 ιέ 1 I 9 (1 986 年) ,厂 睜藥 ib 學期刊 (j. He d . Che m . ) J 37卷 之 注 意 1 1 I 2 32 頁( 1 994 年) r生物有機及》藥化學ώ(Βί〇Μβ&lt;1 • Ch e η * 事 項 1 I 再 I L e tt .) J 2卷,755頁 * (1992年), 厂 美 國 化 學 協 會 期 刊 ( 填 寫 本 1 裝 j. A m . Ch e m « S 〇 c . )J 115卷 9025 頁 (1993年) t 厂 有 櫬 化 頁 I 學 期 刊 (J * 0 r g . Che m . )j 57卷 2873頁(1992年 ) 特開平 1 1 3- 128379 * 特開 平6- 116269)= 1 1 式 (I )所示之化合物可簞獨 或與- -種以上習知的%繭容 1 訂 許 輔 肋 劑 共 同做 為抗 菌 、抗腫 瘤組 成 物 且 可 Μ 錠 劑 &gt; 膠 1 1 囊 劑 散 劑 、顆 粒劑 安瓿劑 等經 口 或 非 經 0 劑 供 應 〇 1 1 I 於 非 經 口 使用 之情 形 ,亦可 以靜 脈 内 投 予 Λ 動 脈 内 投 予 1 1 腹 腔 内 投 予、 皮下 投 予、肌 肉内 投 予 胸 腔 內 投 予 或 局 1 線 部 投 予 等 〇 1 例 如 將 式 (1)所示之化合物 或其鹽於生理食鹽水和葡 1 萄 糖 &gt; 甘 露 酵、 乳糖 等 水溶液 中溶 解 作 成 適 當 的 Β 藥 組 成 1 1 1 物 Ο 又 式 (1)所示化合物之鹽亦可依常法冷凍乾煉 ,並 1 1 於 其 中 加 入 氣化 納等 作 成粉末 注射 劑 0 更 且 » 本 m 組 成 1 1 物 視 爾 要 可 含有 製劑 領 域習知 之添 加 劑 &gt; 例 如 製 劑 容 許 鹽 1 I 等 〇 1 I 投 予 量 雖 依患 者年 舲 、症狀 而異 9 但 對 於 包 含 人 之 哺 乳 1 1 | 動 物 Μ 0 · 00001〜100 毫 克/公斤/日 0 投 予 為 例 如 以 1曰1 回 1 1 - 1 η _ 本紙张尺度適用中國阈家標苹(ΓΝ5 ) Λ4規格(210X 297公釐) 19 五、發明説明u 週 A7 B7 回 性 用 有 之 明 Μ 發 地本 欺出 間示 或例 , 胞 。 回實例 數列施 成下實 分依於 或限 2 週 4 侷 〇 被 予不 投並 回明 ί發 本 但 例 腌 實 例 施 實 ~ -3(20) (2a) (Eighth process) In this process, a compound represented by formula (17) (wherein Y1 is Br, I, OS02CF3, X1, X2, and 瑁 A are the same as described above) and formula ( 18) an acrylic acid derivative (wherein R 16 is a methoxy group, an ethoxy group, a benzyloxy group, and Y 2 is a hydrogen atom, a trimethylstannyl group, and a tributylstannyl group.) A tight coupling reaction is carried out under the conditions of the solvent to produce a diacrylate derivative represented by the formula (19). This reaction can be carried out according to a known method (for example, "Lecture on Experimental Chemistry, 4th edition, pages 396 ~ 427, (1991), Jiushan"). (Ninth process) In this process, the diacrylic acid ester represented by formula (19) is derived and the ester of the product is removed, and the diacrylic acid derivative represented by formula (2a) is produced. This reaction can be carried out according to a known method ("Protective Groups in Organic Synthese", pp. 231 to 265, (1991), Johan W i 1 y & Suns). (Tenth process) _This process is to condense the dialdehyde derivative shown in formula (20) and malonic acid. This paper size applies the Chinese National Standard (CNS) Λ4 specification (210X297 mm) I gutter (please Read the notes on the back before filling out this page.) 18 — A7 Printed by the Consumers Cooperative of the Central Standards Bureau, Ministry of Economic Affairs, B7 ——! V. The invention is clear (Η;) 1 1 1 and the manufacturing method (2 a) is shown The second acrylic acid derivative 〇 This reaction can be performed according to the known method 1 1 〇 [Properties please i racemic compounds of the compounds represented by the above formulas (4) and (5) »and its optical activity 1 | According to well-known methods (e.g., &quot; T etrahedr ο η Le 11 · J 27 vol. 4103 p. A back 1 1 9 (1 986), the journal of medicine ib science (j. He d. Che m.) J 37 Attention to Volume 1 1 I 2 32 pages (1 994) r Bioorganic and "Pharmaceutical Chemistry" (Βί〇Μβ &lt; 1 • Ch e η * Matter 1 I and then IL e tt.) J Volume 2, page 755 * ( 1992), Factory Beauty Journal of the Chemical Society of China (fill in 1 pack j. A m. Ch em «S oc.) J 115 Vol. 9025 pages (1993) t Plant Chemicals I Journal (J * 0 rg. Che m.) J 57, p. 2873 (1992) Japanese Patent Application Laid-Open No. 1 1 3- 128379 * Japanese Patent Application Laid-Open No. 6-116269) = 1 1 The compound represented by formula (I) can be used alone or in combination with--more than one conventional% cocoon content 1 Order Xu auxiliary ribs are commonly used as antibacterial and antitumor compositions and can be used in the form of lozenges &gt; gum 1 1 capsules, powders, ampoules, etc. for oral or non-oral administration 0 1 1 I For non-oral use In some cases, it can be administered intravenously Λ intra-arterial administration 1 1 intraperitoneal administration, subcutaneous administration, intramuscular administration, intrathoracic administration, or local first-line administration, etc. 0 1 For example, the formula (1) The compound or its salt is dissolved in a physiological saline solution and glucose 1 &gt; manganese, lactose and other aqueous solutions to form an appropriate B drug composition 1 1 1 substance 0 The salt of the compound represented by formula (1) may also be used as usual Freeze-dried, and add 1 gasification sodium powder to make a powder injection. 0 more »this m composition 1 1 material may contain additives known in the formulation field> For example, the formulation allows salts 1 I, etc. 〇1 I injection Although the dose varies depending on the patient's age and symptoms9, for human breastfeeding 1 1 | Animals M 0 · 00001 to 100 mg / kg / day 0 Dosage is, for example, 1 time 1 times 1 1-1 η _ paper The Zhang scale is applicable to the Chinese threshold family apple (ΓΝ5) Λ4 specification (210X 297 mm) 19 V. Description of the invention u Week A7 B7 Reproduced by the Ming Dynasty, the origin of the issue, or other examples. The actual number of executions of the series is dependent on or within 2 weeks and 4 innings. 〇 It is not voted and the answer is made.

F3 三 第 基 甲 氟 三- 7- 基 羥- 5 I 基 甲 氯 I- 基 羰 氧 並 咯 咁 氫 四 /|\ 60 5 3 1X 酯 甲 酸 羧- 8 I 哚 (請先閱讀背面之注意事項再填寫本頁) 裝. 訂 u 义 拌 酸 烯 丙 與 渣 殘 得 氫所 化。 氯劑 Μ ? 3 溶 入除 加餾(1 中,mg 丨後3 ij. 時 小 及 \1/ A ο In w 基 溫Η基 室Ξ叾 八、/ 彳 - i 一 3 迨 4 - I V)/ 殳(1基m - 芍 6 ο 3’胺 glM 甲叾2二 査 酸 醋 授 下 二 化 碳 線 經满部中央標準局員工消费合作社印裝 鹽 酸 鹽 胺. 亞 胺 醢 甲 基 甲 二 水 無 於 \lr 1 ο w W所 並劑 水溶 加除 中皤 液。 應燥 反乾 於納 。 酸 晚硫 一 水 拌無 撹 Μ 下且 溫取 室萃 下1) 流 : 氣(5 氤酵 , 甲 ϋ仿 m 氯 渣 殘 之 得 得 取 製 03 晶 結 色 析黃 層之 柱¾) 膠25 砂g( 仿 氯 0 丙 酵 甲F3 Tris-n-methylfluorotri-7-ylhydroxy-5 I-methylchloro I-ylcarbonyloxopyrrolidine tetra / | \ 60 5 3 1X ester carboxylic acid carboxyl-8 I indole (Please read the precautions on the back first (Fill in this page again) Packing. Order u Allyl acid and slag residue are hydrogenated. Chlorine agent M? 3 dissolved in addition to distillation (1 in mg, 丨 after 3 ij. Shi Xiao and \ 1 / A ο In w base temperature Η base chamber Ξ 叾 /, / 彳-i-3 迨 4-IV) / 殳 (1 base m-芍 6 ο 3 'amine glM Formaldehyde 2 Dicha acid vinegar awarded dioxin carbon wire. The hydrochloride amine was printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Printing. Water is not dissolved in the water and added to remove the middle mash. It should be dried and then dried. The acid late sulfur is mixed with water without water and extracted in a warm room. 1) Flow: gas (5 enzymes) Formazan imitation m Chlorine residue Residues Obtain 03 pillars with yellow coloration layer ¾) Glue 25 sand g

精 \)/ 1A 苯 雙 U A—/ 基 醢 烯 丙 二 並 咯 氫 四 基 甲 氟 三 ο 一 _—_ -7酷 基甲 羥酸 5-後 基-8 甲哚 氮°3| 本紙張尺度適用中國國家標準(CNS ) Λ4規格(2lOX297公釐) 20 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(1 [a ] 24D= — 2 1。 ( c = 0 . 2 0、四氫呋喃 ) NMR (DMSO dg) δ : 3. 48 (2H. t. J = 8Hz), 3. 8 3 (2H. d, J = 8Hz). 3. 88 (611, s), 4 .28(2H, br), 4. 40-4. 4 9 (4H, m). 7. 30(2H, d. J = 15IIz). 7. 70(211. d. J =1 6Hz), 7. 8 7 (4It ,s), 8. 11 (2H. brs). 10. 52(211, br) . 13. 02 (ZIl.br). 實施例2Refined \) / 1A Benzene UA— / Benzene allyl bis tetrazolium tetrafluoromethylene trifluoride ο ___ _ 7 kuyl methoic acid 5-postyl -8 formyl nitrogen ° 3 | Paper size Applicable to Chinese National Standard (CNS) Λ4 specification (2lOX297 mm) 20 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (1 [a] 24D = — 2 1. (c = 0.20, Tetrahydrofuran) NMR (DMSO dg) δ: 3. 48 (2H. T. J = 8Hz), 3. 8 3 (2H. D, J = 8Hz). 3. 88 (611, s), 4 .28 (2H , br), 4. 40-4. 4 9 (4H, m). 7. 30 (2H, d. J = 15IIz). 7. 70 (211. d. J = 6Hz), 7. 8 7 ( 4It, s), 8. 11 (2H. Brs). 10. 52 (211, br). 13. 02 (ZIl.br). Example 2

(S)-3-第三丁氧羰基-卜氛甲基-5-羥基-7-三氟甲基 -1,2,3,6-四氫咁咯並[3,21]吲哚-8-羧酸甲酯13.511^(30 w m〇A )中加入3M氯化氫-醋酸乙酯0.43mA並於室湛下放 置2小時後,餾除溶劑。所得殘渣與3,3’-(9,10 -憩二基) 二丙烯酸4.8mg(15W m〇A )及1-(3-二甲胺丙基)-3-乙基碳 化二亞胺鹽酸iiU.SmgOOw moil )於無水二甲基甲酿胺 0 . 3 m Λ中氩氣流下室溫下攪拌一晩。於反應液中加水,漶 取析出之沈澱,並以矽膠柱層析(四氫呋喃:氯仿=2: 1) 精製,取得 3.7mg(25:U 之黃色結晶(S,S)-3,3’-[3,3’-(9, 10-蔥二基)二丙烯醢基]雙-[1-氯甲基-5-羥基-7-三氟甲 基-1,2,3,6 -四氫η比咯並[3,2-e]吲哚-8 -羧酸甲酯]。 本紙張尺度適用中阀國家標準(CNS ) Λ4規格(210X 297公f ) I---------裝一------訂------線 (請先聞讀背面之注意事項再填寫本頁) 21 經濟部中央標準局KK工消費合作社印製 A7 B7 五、發明锐明(jJ) 2 9 C a ] D =-144°(c = 〇-〇5' 四氫呋喃 ) N M R ( DM S O d g) δ : 3. 56 (2H, t. J = 10l!z), 3. 7 9-3. 8 5 (2H. m), 3. 87 (6H, s ),4. 22-4. 2 9 (2H. m). 4. 33-4. 47 (411. m). 7. 0 5 (211. d, J = 16Hz), 7. 66 (411, dd. J = 4 ^ 7Ilz). 8. 22(211, s). 8. 3 7(d!i. dd. J = 7 yj 4Hz), 8. 5 5 (2H, d, J = 16Ilz), 10. 6 4(2H. s) .13. 11(2H. s). 實施例3(S) -3-Third-butoxycarbonyl-benzoylmethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3,21] indole-8 -To methyl carboxylate 13.511 ^ (30 wmOA) was added 3M hydrogen chloride-ethyl acetate 0.43 mA and left in the chamber for 2 hours, and then the solvent was distilled off. The obtained residue was mixed with 3,3 '-(9,10-cyclodiyl) diacrylic acid (4.8 mg (15 W mOA)) and 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride iiU. SmgOOw moil) was stirred at room temperature under an argon stream in anhydrous dimethylformamide 0.3 m Λ. Water was added to the reaction solution, and the deposited precipitate was decanted and purified by silica gel column chromatography (tetrahydrofuran: chloroform = 2: 1) to obtain 3.7 mg (25: U of yellow crystal (S, S) -3,3'- [3,3 '-(9, 10-Allium diyl) dipropenyl] bis- [1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydro η is better than pyrro [3,2-e] indole-8-carboxylic acid methyl ester]. This paper size is applicable to the National Standard for Valves (CNS) Λ4 specification (210X 297 male f) I -------- -Install one --- order ------ line (please read the precautions on the back before filling out this page) 21 Printed by the KK Industrial Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. The invention is sharp (JJ) 2 9 C a] D = -144 ° (c = 〇-〇5 'tetrahydrofuran) NMR (DM SO dg) δ: 3. 56 (2H, t. J = 10l! Z), 3. 7 9 -3. 8 5 (2H. M), 3. 87 (6H, s), 4. 22-4. 2 9 (2H. M). 4. 33-4. 47 (411. m). 7. 0 5 (211. d, J = 16Hz), 7. 66 (411, dd. J = 4 ^ 7Ilz). 8. 22 (211, s). 8. 3 7 (d! I. Dd. J = 7 yj 4Hz), 8. 5 5 (2H, d, J = 16Ilz), 10. 6 4 (2H. S). 13. 11 (2H. S). Example 3

依同樣之方法,由(S)-3-第三丁氧羰基-卜氯甲基-5-羥 基-7-三氟甲基-1,2,3,6-四氫吡咯並[3,2-e]吲哚-8-羧酸 甲酯13.51^(30/«111〇]1)與3,3’-(5,8-二甲氧基-1,4-萘二 基)二丙烯酸 4.9mgi(15w m〇A),取得 2.2mg(15S!)之(S.S) -3,3’- [3,3·-( 5,8 -二甲氧基-1,4 -禁二基)二丙烯釀基]雙 -[卜氯甲基-5-羥基-7 -三氟甲基-1,2,3,6-四氫吡咯並 [3 , 2 - e )吲哚-8 -羧酸甲酯。 [a]D3()=-56。 (c = 0. 05、四氫呋喃 ) NMR (DMSO d g) δ : 3. 5 2 (2Η, dd. J = 9 and llllz). 3. 80-3. 87 (211, m), 3. 88(6H,s),3.89(6H.s).4.23 — 4.31(2H.m),4.4〇-4.47Ull,m),6.77(2H,d,J = 15Hz),7· 10(2H.s).7.75(2H.s).8.16(2II,s),8.77(2II.d,J = lSHz).10.54(211.s),13.06(2Il,s) 實施例 ----------t-丨-----IT------A (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Λ4規格(21〇X 297公犛) 22 O O - Μ Β7 經濟郎中央標_局員工消費合作社印製 五、發明説明(;j(丨)In the same way, (S) -3-Third-butoxycarbonyl-buchloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3,2 -e] indole-8-carboxylic acid methyl ester 13.51 ^ (30 / «111〇] 1) and 3,3 '-(5,8-dimethoxy-1,4-naphthalenediyl) diacrylic acid 4.9 mgi (15w m〇A), and obtained 2.2mg (15S!) of (SS) -3,3'- [3,3 ·-(5,8 -dimethoxy-1,4 -bi-diyl) di Propylene group] Bis-[[Bloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3, 2-e]) indole-8-carboxylic acid ester. [a] D3 () =-56. (C = 0.05, tetrahydrofuran) NMR (DMSO dg) δ: 3. 5 2 (2Η, dd. J = 9 and llllz). 3. 80-3. 87 (211, m), 3. 88 (6H , s), 3.89 (6H.s). 4.23 — 4.31 (2H.m), 4.40-1.47Ull, m), 6.77 (2H, d, J = 15Hz), 7.10 (2H.s). 7.75 (2H.s). 8.16 (2II, s), 8.77 (2II.d, J = lSHz). 10.54 (211.s), 13.06 (2Il, s) Examples ---------- t -丨 ----- IT ------ A (Please read the precautions on the back before filling out this page) This paper size applies to Chinese National Standard (CNS) Λ4 specification (21〇X 297 cm) 22 OO -Μ Β7 Economic Lang Central Standard _Printed by Bureau Consumer Consumption Cooperative V. Invention Description (; j (丨)

依同樣之方法,由(S)-3-第三丁氧羰基-1-氯甲基-5-羥 基-7-三氟甲基-1,2,3,6-四氫》比咯並[3,2-e]吲哚-8-羧酸 甲酯26.911^(60/^111〇]1)與3,3’-(2,3-(乙二氧撐)-1,4-伸 苯基]二丙烯酸8.31!^(30/^111〇]1),取得4.111^(15:1!)之(5,5) -3,3’-[3,3’- (2,3-(乙二氧撐)-1,4-伸苯基)二丙稀醢基] 雙-[1-氛甲基-5-羥基-7 -三氟甲基-1,2 ,3,6 -四氫叫:咯並[ 3 , 2 - e ]吲哚-8 -羧酸甲酯]。 [α ] 〇3° =-12° ( c = Ο . Ο 5.四氫呋哺 ) Ν Μ R ( D Μ S Ο d g) δ : 3. 5 1 (2H, t. J-1 ΟΗζ), 3. 7 9-3. 8 5 ( 2Η. in), 3. 88 (611, s), 4. 2 3-4. 3 2 (ΖΗ, m), 4. 38-4. 4 4 ( 4 Η, m). 4. 46(4 Η. s). 7. 25(2Η,d, J = 16Hz), 7. 5 2(2H,s). 7. 8 9 (2H.d. J = 16!Iz), 8. 10(211. s). 10. 56(211, s). 13. 07(211. s). 實施例5In the same way, (S) -3-Third-butoxycarbonyl-1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydro "pyrrolo [ 3,2-e] indole-8-carboxylic acid methyl ester 26.911 ^ (60 / ^ 111〇) 1) and 3,3 '-(2,3- (ethylenedioxylene) -1,4-benzene Based] diacrylic acid 8.31! ^ (30 / ^ 111〇) 1), obtain 4.111 ^ (15: 1!) Of (5,5) -3,3 '-[3,3'- (2,3- ( Ethylenedioxane) -1,4-phenylene) dipropylfluorenyl] bis- [1-lanemethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydro Called: Paro [3, 2-e] indole-8-carboxylic acid methyl ester] [α] 〇3 ° = -12 ° (c = 〇. Ο 5. Tetrahydrofuran) NM R (D Μ S 〇 dg) δ: 3. 5 1 (2H, t. J-1 ΟΗζ), 3. 7 9-3. 8 5 (2Η. In), 3. 88 (611, s), 4. 2 3 -4. 3 2 (ZΗ, m), 4. 38-4. 4 4 (4 Η, m). 4. 46 (4 Η. S). 7. 25 (2Η, d, J = 16Hz), 7 5 2 (2H, s). 7. 8 9 (2H.d. J = 16! Iz), 8. 10 (211. S). 10. 56 (211, s). 13. 07 (211. S ) Example 5

_依同樣之方法,由(S)-3-第三丁氧羰基-1-氯甲基-5-羥 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公婕) -----------裝l·-----訂------線 (請先閱讀背面之注意事項再填寫本頁) -23 - 經濟部中央標卒局負工消費合作社印製 A7 B7五、發明説明Ul) 基-7-三氟甲基-1,2,3,6-四氫η比咯並[3,2-e]吲哚-8-羧酸 甲酷 13.5mg(3〇w moil )與 3,3’-[2,3-(甲二氧樓)-1,4 -伸 苯基]二丙烯酸 3.9mg(15w m〇A ),取得(S,S)-3,3’-[3,3’ -(2,3-(甲二氧撐)-1,4 -伸苯基)二丙烯醢基]雙-[1-氯甲 基-5 -羥基-7 -三氟甲基-1,2,3,6 -四氫喀並[3,2-e]吲哚 -8-羧酸甲基]。 「 1 30 。 — L a J D =— 12 ( c = 〇 . 05、四氫呋喃 ) NMR(DMSO d g) δ : 3. 52 (2H, dd. J = 9 /¾ 11Hz), 3. 78-3. 85 (ZH, m). 3 88 (6H. s). 4. 2 4-4. 3 2 ( 211. m). 32H.i5(4H, ,).6. 38 (211. s), 7. 28(211. d.; = 16Hz). 737(2H.s),7.65(2II.d. J = 16HZ).8. 10(21!, s), 10.58(2H,s), 13. 17(211. s). 實胞例6_According to the same method, the paper size of (S) -3-third butoxycarbonyl-1-chloromethyl-5-hydroxyl applies to the Chinese National Standard (CNS) Λ4 specification (210X297). ----- ------ install l · ----- order ------ line (please read the notes on the back before filling this page) -23-Printed by the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention Ul) 1-7 mg of tris-7-trifluoromethyl-1,2,3,6-tetrahydron ratio to pyrro [3,2-e] indole-8-carboxylic acid methyl ester 3〇w moil) and 3,3 '-[2,3- (methyldioxy building) -1,4-phenylene] diacrylic acid 3.9mg (15w m〇A) to obtain (S, S) -3 , 3 '-[3,3'-(2,3- (methyldioxy) -1,4-phenylene) dipropenyl] bis- [1-chloromethyl-5 -hydroxy-7- Trifluoromethyl-1,2,3,6-tetrahydrocarbo [3,2-e] indole-8-carboxylic acid methyl]. "1 30. — L a JD = — 12 (c = 0.05, tetrahydrofuran) NMR (DMSO dg) δ: 3. 52 (2H, dd. J = 9 / ¾ 11 Hz), 3. 78-3. 85 (ZH, m). 3 88 (6H. S). 4. 2 4-4. 3 2 (211. m). 32H.i5 (4H,,). 6. 38 (211. s), 7. 28 (211.d .; = 16Hz). 737 (2H.s), 7.65 (2II.d. J = 16HZ). 8.10 (21 !, s), 10.58 (2H, s), 13. 17 (211 s). Example 6

依同樣之方法,由(S)-3-第三丁氧羰基-1-氛甲基-5-羥 基-7-三氟甲基-1,2,3,6-四氫咁咯並[3,2-6]吲哚-8-羧酸 甲酯 26.9mg(60w moil )與 3,3’-(2,3-二乙基-1,4-伸苯基) 二丙烯酸 8.2mg(3〇w moil ),取得 5.5mg(20!U)之(S,S)-3,3 ’-[3,3 ’-(2,3-二乙基-1,4-伸苯基)二丙烯醣基]雙-[1-氛 甲基-5 -羥基-7 -三氟甲基-1,2,3,6 -四氫》比咯並[3,2-e]吲 哚-8-羧酸甲酯]。 本紙張尺度適用中國國家標準·( CNS ) Λ4規格(210X297公漦) -----------裝—------訂------絲--1 (請先閱讀背面之注意事項再填寫本頁) -24 - Μ Β7 經濟部中央標準局員工消費合作社印製 五、發明説明(㈡) [a]D31=-16e (c = 0.05、四氫呋喃 )In the same way, (S) -3-Third-butoxycarbonyl-1-aminomethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3 , 2-6] Indole-8-carboxylic acid methyl ester 26.9mg (60w moil) and 3,3 '-(2,3-diethyl-1,4-phenylene) diacrylic acid 8.2mg (3〇 w moil) to obtain 5.5 mg (20! U) of (S, S) -3,3 '-[3,3'-(2,3-diethyl-1,4-phenylene) dipropenose Propyl] bis- [1-naphthylmethyl-5 -hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydro "than pyrro [3,2-e] indole-8-carboxylic acid Methyl ester]. This paper size applies to Chinese National Standards (CNS) Λ4 specification (210X297 cm) ----------- installation --------- order ------ silk--1 (please (Please read the notes on the back before filling this page) -24-Μ Β7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (发明) [a] D31 = -16e (c = 0.05, tetrahydrofuran)

NMR (DMSO d .) δ : 1. 18 (G H. t. J = 8 Hz). 2. 8 5 (4 H, q, J = 8Ηζ), 3. 51 (2Η, t. J 6NMR (DMSO d.) Δ: 1. 18 (G H. t. J = 8 Hz). 2. 8 5 (4 H, q, J = 8Ηζ), 3. 51 (2Η, t. J 6

= 10Hz). 3 . 7 2-3. 8 5 ( 2H. m). 3. 88(6H, s). 4. 2 2-4. 32 (211. m), 4. 38-4. 48 (4H. m). 7. 12(2 H.d.J = 16Hz).7.78(2H.s),7.99(211,d,J = 16Hz).8.11(2H,s).10.54(2H,s),13.06(2H ,s). 實施例7= 10Hz). 3. 7 2-3. 8 5 (2H. M). 3. 88 (6H, s). 4. 2 2-4. 32 (211. m), 4. 38-4. 48 ( 4H.m). 7. 12 (2 HdJ = 16Hz). 7.78 (2H.s), 7.99 (211, d, J = 16Hz). 8.11 (2H, s). 10.54 (2H, s), 13.06 (2H , s). Example 7

依同樣之方法,由(S)-3 -第三丁氧羰基-1-氯甲基-5-羥 基-7-三氟甲基-1,2,3,6-四氫吡咯並[3,21]吲哚-8-羧酸 甲酯13.511^(30«1!1〇]1)與3,3’-(2,3-二甲氧基-1,4-伸 苯基)二丙烯酸 4.2mg(15« moil ),取得 2.1fflg(15!〇 之(S.S) -3,3’- [3,3·-(2,5-二甲氧基-1,4 -伸笨基)二丙烯醢基] 雙-[1-氛甲基-5 -羥基-7-三氟甲基-1,2,3,6-四氫叫:咯並 [3 , 2 - e ]吲°朵-8 -羧酸甲酯]。 Ί η C a ] D = 一 56。 (c = 0.05、四氬咲喃 ) NMR (DMSO d 6) 5:3. 52 (2H, dd. J = 8 孩 11Hz), 3. 78-3. 90 (211, m), 3. 88 (G!I. s). 3. 98 (6H, s). 4. 2 3 -4. 3 3 ( 211. m). -1. 38-4. 48 (4H. m). 7. 30(2H, d, J = 16Hz), 7. 53 (2H. s). 7. 96(211, d. J = 16Hz), 8. 10(211. s), 10. 56 (2H, s). 13. 07(211, s). 實施例8 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公t ) I 裝 訂 線 (請先閱讀背面之注意事項再填寫本頁) 25 A7 B7 經濟部中央標準局貝工消費合作社印製 五、發明锐明d)In the same way, from (S) -3 -Third-butoxycarbonyl-1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3, 21] Indole-8-carboxylic acid methyl ester 13.511 ^ (30 «1! 1〇] 1) and 3,3 '-(2,3-dimethoxy-1,4-phenylene) diacrylic acid 4.2 mg (15 «moil) to obtain 2.1 fflg (15! 〇 of (SS) -3,3'- [3,3 ·-(2,5-dimethoxy-1,4-benzyl) dipropylene Fluorenyl] bis- [1-lanemethyl-5 -hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydro is called: pyrro [3, 2-e] ind ° -8- Methyl carboxylate]. Ί η C a] D =-56. (c = 0.05, tetraargon) NMR (DMSO d 6) 5: 3. 52 (2H, dd. J = 8 and 11 Hz), 3 78-3. 90 (211, m), 3. 88 (G! I. S). 3. 98 (6H, s). 4. 2 3 -4. 3 3 (211. m). -1. 38-4. 48 (4H. M). 7. 30 (2H, d, J = 16Hz), 7. 53 (2H. S). 7. 96 (211, d. J = 16Hz), 8. 10 ( 211. s), 10. 56 (2H, s). 13. 07 (211, s). Example 8 This paper size applies to the Chinese National Standard (CNS) Λ4 specification (210X297mm t) I Gutter (please read first Note on the back, please fill out this page) 25 A7 B7 Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

依同樣之方法,由(S)-3 -第三丁氧羰基-1-氛甲基-5 -羥 基-7-三氟甲基-1,2,3,6-四氫》比咯並[3,21]吲哚-8-羧酸 甲醋 13.5mg(3〇w m〇A )與 3,3'-(2,5-二甲氧基-1,4-伸苯 基)二丙烯酸 4.2mg(15w moil),取得 l.lmg(8S!) 2(S,S)-3,3’- [3,3'-(2, 3-二甲氧基-1,4 -伸苯基)二丙烯醢基]雙 -[1-氯甲基-5-羥基-7 -三氟甲基-1,2,3,6-四氫》it咯並 [3 , 2-e]吲哚-8-羧酸甲酯]。 [a]D32=— 26。 (c = 0.05、四氫呋哺 ) NMR (DMSO d J δ :3.51 (2H, del, J = 9 /1 10Hz). 3. 7 9-3. 94 (2H, in), 3. 6 88 (6H. s), 3. 90 (6H, s), 4. 24-4. 3 3 ( 2H.ni). 4. 3 9-4. 4 9 (411, m), 7. 31(2H,d, J = 16Hz), 7. 78(2H,s),7.88(2H,d.J = 16IIz),8.11(2H.s).10.57(2H,s),13.08(2H.s). 實施例9In the same way, (S) -3 -Third-butoxycarbonyl-1-aminomethyl-5 -hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydro 13.5 mg of 3,21] indole-8-carboxylic acid methyl ester (30 wm0A) and 4.2 mg of 3,3 '-(2,5-dimethoxy-1,4-phenylene) diacrylic acid (15w moil) to obtain 1.1 mg (8S!) 2 (S, S) -3,3'- [3,3 '-(2, 3-dimethoxy-1,4-phenylene) di Allyl] bis- [1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydro "it pyrro [3, 2-e] indole-8- Methyl carboxylate]. [a] D32 = — 26. (C = 0.05, tetrahydrofuran) NMR (DMSO d J δ: 3.51 (2H, del, J = 9/1 10Hz). 3. 7 9-3. 94 (2H, in), 3. 6 88 ( 6H. S), 3. 90 (6H, s), 4. 24-4. 3 3 (2H.ni). 4. 3 9-4. 4 9 (411, m), 7. 31 (2H, d , J = 16Hz), 7. 78 (2H, s), 7.88 (2H, dJ = 16IIz), 8.11 (2H.s). 10.57 (2H, s), 13.08 (2H.s). Example 9

依囘樣之方法,由(S)-3 -第三丁氧羰基-卜氛甲基-5 -羥 基-7-三氟甲基-1,2,3,6-四氫咁咯並[3,2-6]吲哚-8-羧酸 甲酯13.511^(30/1(111〇]1)與3,3'-(1,1’-二苯基-4,4'-二基) 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公嬸) 裝 訂 線 (請先閱讀背面之注意事項再填寫本頁) 26 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明 二丙烯酸 4.4mg(15u m〇A ),取得 1.7mg(12!U 之(S,S)-3,3’ -[3,3'-(1,1·-二苯基-4.4’-二基)二丙烯醯基]雙-[卜氯 甲基-5-羥基-7-三氟甲基-1,2,3,6-四氫%咯並[3, 2-e]吲 哚-8 -羧酸甲酯]。 [(^/2=-36° (c = 0. 05、四氫呋喃 ) N M R ( D M S 0 d ,) δ : 3. 50(211. dd. J = 9 /¾ 11Hz). 3. 78-3. 90 (2H. m). 3. 0 88(611, s), 4. Z3-4. 32(211. m), 4. 3 8-4 . 5 2 ( 4 11, in), 7. 29(2H, d, J = 15Hz), 7. 71(2H. d, J = 1 5Hz). 7. 84(4H, d, J = 8Hz), 7. 9 3 (4H, d, J = 8IIz), 8. 11 (2H, s), 10. 5 8 (2H, s), 13. 07 (ZH, s ). 實施例10According to the same method, (S) -3 -Third-butoxycarbonyl-bufamylmethyl-5 -hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrene [3] , 2-6] indole-8-carboxylic acid methyl ester 13.511 ^ (30/1 (111〇) 1) and 3,3 '-(1,1'-diphenyl-4,4'-diyl) This paper size applies the Chinese National Standard (CNS) Λ4 specification (210X 297 cm) binding line (please read the notes on the back before filling this page) 26 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention 4.4 mg (15 u mOA) of diacrylic acid, 1.7 mg (12! U of (S, S) -3,3 '-[3,3'-(1,1 · -diphenyl-4.4'-di Propyl) dipropenyl] bis- [chlorochloro-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydro% pyrrolo [3, 2-e] indole-8 -Methyl carboxylate]. [(^ / 2 = -36 ° (c = 0.05, tetrahydrofuran) NMR (DMS 0 d,) δ: 3.50 (211. dd. J = 9 / ¾ 11Hz). 3. 78-3. 90 (2H. M). 3. 0 88 (611, s), 4. Z3-4. 32 (211. M), 4. 3 8-4. 5 2 (4 11, in ), 7. 29 (2H, d, J = 15Hz), 7. 71 (2H. D, J = 1 5Hz). 7. 84 (4H, d, J = 8Hz), 7. 9 3 (4H, d , J = 8IIz), 8. 11 (2H, s), 10. 5 8 (2H, s), 13. 07 (ZH, s). Example 1 0

依同樣之方法,由(S)-3 -第三丁氧羰基-卜氛甲基-5 -羥 基-7-三氟甲基-1,2,3.6-四氫咁咯並[3,2-e]吲哚-8-羧酸 甲酯13.511^(30//111〇]1)與3,3’-(1,4-萘二基)二丙燔酸 LOnigdSii m〇A ),取得 3.0mg(22S!)之(S,S)-3,3,-[3,3' — (1,4-萘二基)二丙烯醯基]雙-[1-氯甲基-5-羥基-7-三氟 甲基-1,2,3,6-四氫咁咯並[3,2-e]吲哚-8-羧酸甲酯]。 本紙張尺度適用中國國家榡準(CNS ) Λ4規格(210X297公康) ----------^-丨-----,訂------.^ (請先閱讀背面之注意事項再填寫本頁) 27 經濟部中央標準局員工消費合作杜印製 A7 B7 五、發明説明(⑸) [« ] = - 4 1 ° ( c = 0 · 0 5、四氫呋喃 ) N M R (D M S Ο d ,) δ : 3. 53 (2Η. t, J = 1 〇Ηζ), 3. 78-3. 9 2 (2Η.m).3.88(6Η.s), Ο 4. 2 5-4. 34 (2H.in). 4. 4 5-4. 54 (iH.m). 7. 3 6(2H,d. J = 15IIz). 7. 7 4(ZII.dd, J = 3 jk 6In the same way, (S) -3 -Third-butoxycarbonyl-bufamylmethyl-5 -hydroxy-7-trifluoromethyl-1,2,3.6-tetrahydropyrrolo [3,2- e) Indole-8-carboxylic acid methyl ester 13.511 ^ (30 // 111〇) 1) and 3,3 '-(1,4-naphthalenediyl) dipropionate (LonigdSii mOA), 3.0 mg was obtained (22S!) Of (S, S) -3,3,-[3,3 '— (1,4-naphthalenediyl) dipropenylfluorenyl] bis- [1-chloromethyl-5-hydroxy-7 -Trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3,2-e] indole-8-carboxylic acid methyl ester]. This paper size is applicable to China National Standard (CNS) Λ4 specification (210X297 Gongkang) ---------- ^-丨 -----, order ------. ^ (Please read the back first Please pay attention to this page, please fill in this page) 27 Consumer Cooperation of Central Standards Bureau, Ministry of Economic Affairs, Du printed A7 B7 V. Description of Invention (⑸) [«] =-4 1 ° (c = 0 · 0 5, Tetrahydrofuran) NMR (DMS 〇 d,) δ: 3. 53 (2Η.t, J = 1 〇Ηζ), 3. 78-3. 9 2 (2Η.m) 3.88 (6Η.s), 〇 4. 2 5-4. 34 (2H.in). 4. 4 5-4. 54 (iH.m). 7. 3 6 (2H, d. J = 15IIz). 7. 7 4 (ZII.dd, J = 3 jk 6

Hz). 8. 16 (2H. s). 8. 20(211. s). 8. 36 (2il. dd. J = 6 /5 31!z). 8. 51(211.d, J = 15Hz). 10 .60(2H, s).13.09(2H, s). 實施例1 1Hz). 8. 16 (2H. S). 8. 20 (211. S). 8. 36 (2il. Dd. J = 6/5 31! Z). 8. 51 (211.d, J = 15Hz ). 10 .60 (2H, s). 13.09 (2H, s). Example 1 1

依同樣之方法,由(S)-3-第三丁氧羰基-1-氮甲基-5-羥 基-7 -三氟甲基-1,2,3,6-四氫吡咯並[3,2-e]吲«-8 -羧酸 甲酯13.511^(30;1&lt;111〇又)與3,3’-(1,4-憩二基)二丙烯酸4.8 mg(15y m〇A ),取得 2.3mg(16!U 之(S,S)-3,3'-[3,3’-(l,4 -葱二基)二丙烯醯基]雙-[1-氯甲基-5-羥基-7-三氟甲基-1,2 ,3,6 -四氫0H:咯並[3,2-e]吲哚-8-羧酸甲酯]。 — 36。 (c = 0. 05、四氣咲喃 ) NMR (DMSO d J δ : 3. 5 4 (2II. t, J = 1 ΟΙΙζ), 3. 7 8-3. 9 3 ( 211. πι), 3. 8 9 (611. s), 6 4. 27-4. 36(211, m), 4 . 4 6 -4. 5 7 (4Η. m). 7. 43(2H, d. J = 15Hz), 7. 62(211. dd, J = 3 }l 6 Hz). 8. 19(411, s), 8. 30(2H, dd. J = 6 3 Hz), 8. 6 7 (211, d, J = 15 Hz), 9. 0 4 (ZH, s), 1 〇 .60(211, s), 13. 07(2H, s). 實施洌1 2 木紙張尺度適用中阈國家標準(CRS ) Λ4規格(210X297公漦) _ 2 8 - I 訂 線 (請先閱讀背面之注意事項再填寫本頁) A7 B7 經濟部中央榡準局貝工消费合作社印製 五、發明説明(:%)In the same way, (S) -3-Third-butoxycarbonyl-1-nitromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3, 2-e] ind «-8-carboxylic acid methyl ester 13.511 ^ (30; 1 &lt; 111〇 and) and 3,3 '-(1,4-cyclodiyl) diacrylic acid 4.8 mg (15 μm〇A), (2.3! (16! U of (S, S) -3,3 '-[3,3'-(l, 4-allium diyl) dipropenylfluorenyl] bis- [1-chloromethyl-5- Hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydro 0H: pyrro [3,2-e] indole-8-carboxylic acid methyl ester].-36. (c = 0.05 , Tetragas sulfonation) NMR (DMSO d J δ: 3. 5 4 (2II. T, J = 1 ΟΙΙζ), 3. 7 8-3. 9 3 (211. π), 3. 8 9 (611. s), 6 4. 27-4. 36 (211, m), 4. 4 6 -4. 5 7 (4Η. m). 7. 43 (2H, d. J = 15Hz), 7. 62 (211 dd, J = 3} l 6 Hz). 8. 19 (411, s), 8. 30 (2H, dd. J = 6 3 Hz), 8. 6 7 (211, d, J = 15 Hz) , 9. 0 4 (ZH, s), 1 〇.60 (211, s), 13. 07 (2H, s). Implementation 洌 1 2 Wood paper standard applies the mid-threshold national standard (CRS) Λ4 specification (210X297)漦) _ 2 8-I Order (Please read the precautions on the back before filling this page) A7 B7 Printed by the Shellfish Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Description (:%)

依同樣之方法,由(S)-3 -第三丁氧羰基-1-氛甲基,5 -羥 基-7 -三氟甲基-1,2,3,6 -四氫项:咯並[3,2-e]吲哚-8-羧酸 甲酯40.4|118(90&lt;/111〇]1)與3,3’-(9,10-二氫_9.10-二氧基_ 1,4-憩二基)二丙烯酸 15.7mg(45w moil ),取得 1.6mg(4n 之(S,S)-3, 3'-[3,3’-(9,10 -二氫-9,10-二氧基-1,4 -葱二 基)二丙烯醯基]雙-[1-氯甲基-5-羥基-7-三氟甲基-1,2,3 ,6 -四氫咁咯並[3,2-e]吲哚-8 -羧酸甲酯]。 3 7 [a]D=-48°(c = 〇. 〇5、四氫呋哺 ) N M R ( D M S Ο d g) δ : 3. 53 (2Η. dd. J-9 茂 10Hz), 3. 79-3. 91 (2H, m). 3. 88(6H, s). 4. 2 4-4. 3 4 ( 211. m), 4. 41-4. 51 (4H. m), 7. 11 (211, d, J = 16ilz), 7. 95(211. dd. J = 3 Jl 6Hz). 8. 10-8. 19(411, m). 8. 21(21!, s), 8. 5 3 (211. d, J = 16IIz), 10. 61(211, s), 13 .10(2H, s). 實施例13In the same way, from (S) -3 -Third-butoxycarbonyl-1-aminomethyl, 5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydroterm: 3,2-e] indole-8-carboxylic acid methyl ester 40.4 | 118 (90 &lt; / 111〇) 1) and 3,3 '-(9,10-dihydro_9.10-dioxy_1,4 -Didiyl) 15.7mg (45w moil) of diacrylic acid, 1.6mg (4n of (S, S) -3, 3 '-[3,3'-(9,10-dihydro-9,10-di) Oxy-1,4-allium diyl) dipropenylfluorenyl] bis- [1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [ 3,2-e] indole-8-carboxylic acid methyl ester] 3 7 [a] D = -48 ° (c = 0.05, tetrahydrofuran) NMR (DMS 0 dg) δ: 3. 53 (2Η. Dd. J-9 Mo 10Hz), 3. 79-3. 91 (2H, m). 3. 88 (6H, s). 4. 2 4-4. 3 4 (211. m), 4. 41-4. 51 (4H. M), 7. 11 (211, d, J = 16ilz), 7. 95 (211. dd. J = 3 Jl 6Hz). 8. 10-8. 19 (411 , m). 8. 21 (21 !, s), 8. 5 3 (211. d, J = 16IIz), 10. 61 (211, s), 13 .10 (2H, s). Example 13

本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) I--------1 —-----IT------g (請先閱讀背面之注意事項再填寫本頁) 29 經濟部十央標苹局員工消费合作社印製 A7 B7 五、發明説明(:Γ/) 依同樣之方法,由(S)-3-第三丁氧羰基-卜氛甲基-5-羥 基-7 -三氟甲基-1,2, 3,6 -四氫吡咯並[3,2-e]吲哚-8 -羧酸 甲酯13.511^(3(^111〇1)與3,3’-(2,2’-二(1比啶基-5,5'-二 基)二丙烯酸 4.4mg(15;u moil ),取得 2.4mg(17!«)之(S.S)-3,3'-[3,3’-(2,2'-二咁啶基-5,5'-二基)二丙烯醚基]雙-[1-氯甲基-5 -羥基-7 -三氟甲基-1,2,3,6 -四氫咁咯並[3,2 -e]吲哚-8-羧酸甲酯]。 〇]n32=-35° (c = 0.05、四氫咲喃 )This paper size applies to Chinese National Standard (CNS) Λ4 specification (210X 297 mm) I -------- 1 —----- IT ------ g (Please read the notes on the back first (Fill in this page again) 29 A7 B7 printed by the Employees' Cooperative of the Shiyang Standard Bureau of the Ministry of Economic Affairs. 5. Description of the Invention (: Γ /) In the same way, (S) -3-Third-butoxycarbonyl-Puccino Methyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3,2-e] indole-8-carboxylic acid methyl ester 13.511 ^ (3 (^ 111〇1 ) And 3,3 '-(2,2'-di (1 than pyridyl-5,5'-diyl) diacrylic acid 4.4mg (15; u moil), to obtain 2.4mg (17! «) Of (SS ) -3,3 '-[3,3'-(2,2'-Diamidinyl-5,5'-diyl) dipropenyl ether] bis- [1-chloromethyl-5 -hydroxy- 7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3,2-e] indole-8-carboxylic acid methyl ester] 〇] n32 = -35 ° (c = 0.05, Tetrahydrofuran)

D N M R ( D M S Ο d J δ:3. 51(211, dd, J = 9 /¾ 10Hz), 3. 7 7-3. 9 2 ( 2H. m). 3.D N M R (D M S Ο d J δ: 3.51 (211, dd, J = 9 / ¾ 10Hz), 3. 7 7-3. 9 2 (2H. M). 3.

D 88(61i.s),4.25-4_33(211.m),4.39-4_55UH,m),7.47(2il,d,J = 15Hz).7.78(2H,d.J = l 5Hz), 8. 13(211. s). 8. 51(4H, s). 9. 08(2H, s), 10. 60(2H, s), 13. 09(2H. s). 實施例14D 88 (61i.s), 4.25-4_33 (211.m), 4.39-4_55UH, m), 7.47 (2il, d, J = 15Hz). 7.78 (2H, dJ = l 5Hz), 8. 13 (211 s). 8. 51 (4H, s). 9. 08 (2H, s), 10. 60 (2H, s), 13. 09 (2H. s). Example 14

依同樣之方法,由(S)-3 -第三丁氧羰基-卜氯甲基-5 -羥 基-7-三氟甲基-1,2,3,6-四氫咁咯並[3,2-6]吲哚-8-羧酸 甲酯13.51^(30&quot;111〇]1)與3,3'-(1,3-伸苯基)二丙烯酸3.3 tng(15/i moil ),取得 3.5ing(27:i:)之(S,S)-3,3,-[3,3’-(l,3 -伸苯基)二丙烯醢基]雙-[1-氯甲基-5-羥基-7-三氟甲基- 本紙張尺度適用中國國家標率(CNS ) Λ4規格(210X 297公势) . 抑衣 訂^ (請先閱讀背面之注意事項再填寫本頁) -30 - 五、發明诜明(;3) A7 B7 1,2,3,6-四氫啦:咯並[3,2-e]吲哚-8-羧酸甲酯]。 [a]D27=— 28。 (c = 0. 05、四氫呋喃 ) N M R ( D M S Ο d.) δ : 3.51(2H.dd,J = 9 及 10 Hz), 3. 75-3. 93(2 II,η), 3. Ο 88 (6Η,s),4. 2 4-4. 3 3 ( 2 Η. m), 4. 38-4. 5 3 (4H, m).7. 3 3(2H.d, J = 16Hz), 7. 52 (1H, t. J = 8 Hz), 7. 7 3(2H,d. J = 16Hz), 7. 88 (2H. d. J = 8Hz). 8. 1 2 (2H, s), 8. 25 (1II. s), 10. 56 (2H, s) ,13. 06(2H,s). 實施例1 5In the same way, from (S) -3 -Third-butoxycarbonyl-buchloromethyl-5 -hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3, 2-6] Indole-8-carboxylic acid methyl ester 13.51 ^ (30 &quot; 111〇) 1) and 3,3 '-(1,3-phenylene) diacrylic acid 3.3 tng (15 / i moil), obtained 3.5ing (27: i :) of (S, S) -3,3,-[3,3 '-(l, 3-phenylene) dipropenyl] bis- [1-chloromethyl-5 -Hydroxy-7-trifluoromethyl- This paper size applies to China's National Standards (CNS) Λ4 specification (210X 297 public momentum). Yi Yi ^ (Please read the precautions on the back before filling this page) -30- Fifth, invention invention (; 3) A7 B7 1,2,3,6-tetrahydro friends: pyrro [3,2-e] indole-8-carboxylic acid methyl ester]. [a] D27 = —28. (C = 0.05, tetrahydrofuran) NMR (DMS Ο d.) Δ: 3.51 (2H.dd, J = 9 and 10 Hz), 3. 75-3. 93 (2 II, η), 3. Ο 88 (6Η, s), 4. 2 4-4. 3 3 (2 Η. M), 4. 38-4. 5 3 (4H, m). 7. 3 3 (2H.d, J = 16Hz), 7. 52 (1H, t. J = 8 Hz), 7. 7 3 (2H, d. J = 16 Hz), 7. 88 (2H. D. J = 8 Hz). 8. 1 2 (2H, s) , 8. 25 (1II. S), 10. 56 (2H, s), 13. 06 (2H, s). Example 1 5

經濟部中央標準局員工消費合作社印製 依同樣之方法,由(S)-3 -第三丁氧羰基-1-氛甲基-5 -羥 基-7-三氟甲基-1,2,3,6-四氫》比咯並[3,2-6]吲哚-8-羧酸 甲_13.51^(30“ moil )與 3,3’-(1,2-伸苯基)二丙烯酸3.3 mg(15w moil ),取得 3,9mg(30S;)之(S,S)-3,3’-[3,3'-(l,2 -伸苯基)二丙烯醯基]雙-[1-氯甲基-5-羥基-7-三氟甲基-1,2,3,6-四氫咁咯並[3,2-6]吲哚-8-羧酸甲酯]。 28 10 7 〇 . 0 5、四氫呋喃 NMR(DMSO d6)6: 3. 51 (2Ii. t. J = 9!Iz). 3. 7 5-3. 9 2 (2H. &gt;n). 3. 87 (6H. s). 4 .2 2-4. 3 2 (2H. m). 4. 38-4. 50(411. m), 7. 16(211. d. J = 15Ilz), 7. 5 2(ZH, dd. J = 4 fk 6H z), 7. 97 (2H.ro). 8. 0 5(211. d, J = 15Hz). 8. 11 (ZH. s). 10. 57 (2H. s), 13. 0 6 (2H, s). 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公漦) ----------^1:-----ir------M--------- (請先閱讀背面之注意事項再填朽本頁) -〇 1 31 A7 B7 經濟部中央橾導灼員工消费合作社印袋 五、發明説明 實施例16Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs in the same way, from (S) -3 -Third-butoxycarbonyl-1-ammoniamethyl-5 -hydroxy-7-trifluoromethyl-1,2,3 , 6-tetrahydro "than pyrro [3,2-6] indole-8-carboxylic acid methyl_13.51 ^ (30" moil) and 3,3 '-(1,2-phenylene) diacrylic acid 3.3 mg (15w moil) to obtain 3,9mg (30S;) of (S, S) -3,3 '-[3,3'-(l, 2-phenylene) dipropenyl] bis- [1 -Chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3,2-6] indole-8-carboxylic acid methyl ester] 28 10 7 0.05, Tetrahydrofuran NMR (DMSO d6) 6: 3. 51 (2Ii. T. J = 9! Iz). 3. 7 5-3. 9 2 (2H. &Gt; n). 3. 87 (6H s). 4 .2 2-4. 3 2 (2H. m). 4. 38-4. 50 (411. m), 7. 16 (211. d. J = 15Ilz), 7. 5 2 ( EN, dd. J = 4 fk 6H z), 7. 97 (2H.ro). 8. 0 5 (211. d, J = 15Hz). 8. 11 (EN. S). 10. 57 (2H. s), 13. 0 6 (2H, s). This paper size applies Chinese National Standard (CNS) Λ4 specification (210X297 cm) ---------- ^ 1: ----- ir- ----- M --------- (Please read the precautions on the back before filling out this page) -〇1 31 A7 B7 Central Ministry of Economic Affairs of the People's Republic of China, printing bag for consumer cooperatives 16 illustrates an embodiment Ming

依同樣之方法,由(S)-3 -第三丁氧羰基-1-氛甲基-5 -羥 基-7-三氟甲基-1,2,3,6-四氫吡咯並[3,2-6]吲哚-8-羧酸 甲酯27.〇11^(60//111〇艾)與3,3’-(4,4’-(1,1’:4,,1,'-聯三 苯))二丙烯酸 11.2mg(30w moil ),取得 3.1ng(10iU)之(S,S) -3,3,-[3,3’-(3,3”-(1,1,: 4’,1” -聯三苯))二丙烯釀基] 雙-[1-氯甲基-5 -羥基-7-三氟甲基-1,2,3,6 -四氫》比咯並 [3 , 2 - e ]吲°朵-8 -羧酸甲酯]。 28 C * ] D = 一 19。 (c = 〇· 0 5、四氫呋喃 ) NMR(DMSO d g) δ : 3. 51 (2(1, dd. J = 9 ^ 10Hz), 3. 78-3. 94 (211. m). 3. 8 8(611. s). 4. 2 4-4. 3 4 ( 2H, m). 4. 3 9-4. 54 (4H.m). 7. 37(2H,d, J = 15Hz), 7. 58(211. t, J = 8 Hz). 7. 78 (2H, d. J = 15Hz). 7. 81(211, d. J = 8Hz). 7. 8 3(2H. d. J = 8Hz). 7. 9 2(411. s). 8. 13( 2H. s). 8. 18 (2H, s). 10. 5 6(2(1. s). 1 3. 07 (2H, s). 實施例1 7 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) I —^ 裝 ,一吞 線 (請先閲讀背面之注意事項再填寫本頁) 32 A7 B7 經濟部中央標準局員工消费合作社印製 五、發明説明(:川)In the same way, from (S) -3 -Third-butoxycarbonyl-1-aminomethyl-5 -hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3, 2-6] Indole-8-carboxylic acid methyl ester 27.011 (60 // 111〇AI) and 3,3 '-(4,4'-(1,1 ': 4,, 1,' -Bitriphenyl)) 11.2 mg (30w moil) of diacrylic acid, to obtain 3.1 ng (10iU) of (S, S) -3,3,-[3,3 '-(3,3 "-(1,1, : 4 ', 1 ”-bitriphenyl)) dipropenyl] bis- [1-chloromethyl-5 -hydroxy-7-trifluoromethyl-1,2,3,6 -tetrahydro" And [3, 2-e] indodol-8-carboxylic acid methyl ester]. 28 C *] D = one 19. (C = 0.5, tetrahydrofuran) NMR (DMSO dg) δ: 3. 51 (2 (1, dd. J = 9 ^ 10Hz), 3. 78-3. 94 (211. m). 3. 8 8 (611. S). 4. 2 4-4. 3 4 (2H, m). 4. 3 9-4. 54 (4H.m). 7. 37 (2H, d, J = 15Hz), 7 58 (211.t, J = 8 Hz). 7. 78 (2H, d. J = 15Hz). 7. 81 (211, d. J = 8Hz). 7. 8 3 (2H. D. J = 8Hz). 7. 9 2 (411. S). 8. 13 (2H. S). 8. 18 (2H, s). 10. 5 6 (2 (1. S). 1 3. 07 (2H, s). Example 1 7 This paper size applies the Chinese National Standard (CNS) Λ4 specification (210X297 mm) I — ^ Packing, one swallow (please read the precautions on the back before filling this page) 32 A7 B7 Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards

依同樣之方法,由(S)-3-第三丁氧羰基-卜氮甲基-5-羥 基-7-三氟甲基-1,2,3,6-四氫吡咯並[3,2-e]吲«-8-羧酸 甲酯 40.5π^(180« moil )與 3,3’-(4,4’-(1,1’ : 4··1”-聯 三苯))二丙阔酸 5.6mg(15w moil),取得 4.9mg(32X)之 (S,S)-3,3 ’ - [3,3 ’ -(4,4”-(1,1 ’ : 4 ’,1 聯三苯))二丙烯 醯基]雙-[1-氯甲基-5-羥基-7 -三氟甲基-1,2,3,6 -四氫咁 咯並[3 , 2 - e ]吲哚-8 -羧酸甲祁]。 [α]/8=-17° (c = 0. 05、四氫咲喃 i ') N M R ( D M S 0 d J δ : 3. 50 (211, t, J = 1 〇Hz), 3. 7 9-3. 9 3 (2H, m), 3. 88 (6H. s), 0 4. 2 3 -4. 3 3 ( 2H, m). 4. 3 8 -4. 5 3 (4H, m), 7. 29(211, d. J = 16ilz). 7. 72(2H, d, J = 16Hz). 7. 83 (4H, d. J = 8IIz), 7. 88(4H, s). 7. 9 3(411, d. J = 8Hz), 8. 13(211, s), 10. 56(211, s). 13. 06(ZH ,s). 實施例18In the same way, from (S) -3-Third-butoxycarbonyl-azepinemethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3,2 -e] ind ««-8-carboxylic acid methyl ester 40.5π ^ (180 «moil) and 3,3 '-(4,4'-(1,1 ': 4 ·· 1” -terphenyl)) 2 5.6mg (15w moil) of valproic acid, 4.9mg (32X) of (S, S) -3,3 '-[3,3'-(4,4 "-(1,1 ': 4', 1) Bitriphenyl)) Dipropenyl] bis- [1-chloromethyl-5-hydroxy-7-trifluoromethyl-1,2,3,6-tetrahydropyrrolo [3, 2-e] Indole-8-carboxylic acid formaldehyde]. [α] / 8 = -17 ° (c = 0.05, tetrahydrofuran i ') NMR (DMS 0 d J δ: 3. 50 (211, t, J = 1 〇Hz), 3. 7 9 -3. 9 3 (2H, m), 3. 88 (6H. S), 0 4. 2 3 -4. 3 3 (2H, m). 4. 3 8 -4. 5 3 (4H, m) , 7. 29 (211, d. J = 16ilz). 7. 72 (2H, d, J = 16Hz). 7. 83 (4H, d. J = 8IIz), 7. 88 (4H, s). 7 9 3 (411, d. J = 8Hz), 8. 13 (211, s), 10. 56 (211, s). 13. 06 (ZH, s). Example 18

本紙張尺度適用中國罔家標準(CNS ) Λ4規格(21〇X 297公釐) ---------裝—-----訂------線—Γ (請先閱讀背面之注$項再填寫本頁) 33 經濟部中央標準局員工消f合作社印製 A7 B7 五、發明説明(:u ) 依同樣之方法,由(S)-3-第三丁氧羰基-1-氮甲基-5-羥 基-7- 甲基-1,2,3.6-四氫》比咯並[3,2-e]吲哚-8-羧酸 甲酯31.611^(8(^111〇]1)與3,3'-(1,4-伸笨基)二丙烯酸8.7 mg(40iu moil ),取得 8.8mg(29!U 之(S,S)-3,3,-[3,3,-(l,4 -1中I基)二丙烯醯基]雙-Π-氯甲基-5-羥基-7-甲基-1,2,3, 6 -四氫吡喀並[3,2-e]蚓嶸-8 -羧酸甲酯]。 [a]D28= - 15。 (c = 0.05、四氫呋喃 ’) N M R ( D M S Ο ¢1,) δ : 2. 61 (611, s), 3. 41-3. 47 (2Η. m). 3. 80(6H, s). 3. 77-3. 6 90(2H, m), 4 . 2 9 -4. 5 0 ( 611. m), 7. 30 (211, d. J = 15Hz), 7. 66 (ZII, d, J = 15Hz), 7. 87 (4H, s), 7. 93(211. s). 10. 11(211, s), 11. 88(211, s). 實施例19This paper size is applicable to China Standard (CNS) Λ4 specification (21〇X 297 mm) --------- installation ------ order ------ line—Γ (please first Read the note on the back of the page and fill in this page) 33 A7 B7 printed by the staff of the Central Standards Bureau of the Ministry of Economic Affairs F5. Invention description (: u) In the same way, from (S) -3-third butoxycarbonyl -1-nitromethyl-5-hydroxy-7-methyl-1,2,3.6-tetrahydro "than methyl [3,2-e] indole-8-carboxylic acid methyl ester 31.611 ^ (8 (^ 111〇] 1) with 3,3 '-(1,4-benzyl) diacrylic acid 8.7 mg (40iu moil), 8.8 mg (29! U of (S, S) -3,3,-[3 , 3,-(I group in 1,4 -1) dipropenyl] bis-Π-chloromethyl-5-hydroxy-7-methyl-1,2,3,6-tetrahydropyracolo [ 3,2-e] Earthworm-8-methyl carboxylate]. [A] D28 =-15. (c = 0.05, tetrahydrofuran ') NMR (DMS Ο ¢ 1,) δ: 2. 61 (611, s ), 3. 41-3. 47 (2Η. M). 3. 80 (6H, s). 3. 77-3. 6 90 (2H, m), 4. 2 9 -4. 5 0 (611. m), 7. 30 (211, d. J = 15Hz), 7. 66 (ZII, d, J = 15Hz), 7. 87 (4H, s), 7. 93 (211. s). 10. 11 (211, s), 11. 88 (211, s). Example 19

依同樣之方法,由(S)-3 -第三丁氧羰基-1-氱甲基-5 -羥 基-8-甲基-1,2,3,6-四氫咁咯並[3,2-6]吲哚27,〇1^(80 M moil )與 3,3'-(1,4 -伸苯基)二丙烯酸 8.7mg(40w moil ) ,取得13.〇1^(50%)之(5,$)-3,3’-[3,3'-(1,4-伸笨基)二 丙烯醯基]雙-[1-氯甲基-5 -羥基-8 -甲基-1,2,3,6-四氫吡 略並[3,2 - e ] Π3Ι π朵]。 本紙張尺度適用中國罔家標率(CNS ) Λ4規格(210Χ 297公修) 0 , -34- I i 裝 —訂 線 (請先閱讀背面之注意事項再填寫本頁) A7 B7 五、發明説明(:丨2) α ] -42。 c=0. 05、四氮肤喃 經濟部中央標準局負工消费合作杜印製 N M R ( D M S Ο d e) δ : 2. 3 5 (6 H. s), 3. 5 4 - 3. 6 3 (2 H. m). 3. 8 4 - 3. 9 1 (2!!. m), 4. 6 00-4. 10(2Η, m), 4. 3 4-4. 5 4(4Η. m). 7. 03(211. s), 7. Ζ9(2Η, d, J = 16Hz), 7. 6 5 (2H, d, J = 1 6Hz), 7. 78(2H. s), 7. 86(4H, s), 9. 7 5(211, s). 10. 68(2H. s). 實施例20In the same way, (S) -3 -Third-butoxycarbonyl-1-fluorenylmethyl-5 -hydroxy-8-methyl-1,2,3,6-tetrahydropyrrolo [3,2 -6] Indole 27, 〇1 ^ (80 M moil) and 3,3 '-(1,4-phenylene) diacrylic acid 8.7mg (40w moil), obtaining 13.01 ^ (50%) (5, $)-3,3 '-[3,3'-(1,4-benzyl) dipropenyl] bis- [1-chloromethyl-5 -hydroxy-8 -methyl-1 , 2,3,6-tetrahydropyrrolo [3,2-e] Π3Ι π 朵]. This paper size is applicable to Chinese standard rate (CNS) Λ4 specification (210 × 297 public repair) 0, -34- I i Binding-stitching (please read the notes on the back before filling this page) A7 B7 V. Description of the invention (: 丨 2) α] -42. c = 0. 05 、 Working with the Central Standards Bureau of the Ministry of Economics, Ministry of Economic Affairs and Consumer Cooperation Du printed NMR (DMS 〇 de) δ: 2. 3 5 (6 H. s), 3. 5 4-3. 6 3 (2 H. m). 3. 8 4-3. 9 1 (2 !!. M), 4. 6 00-4. 10 (2Η, m), 4. 3 4-4. 5 4 (4Η. m). 7. 03 (211. s), 7. ZO9 (2Η, d, J = 16Hz), 7. 6 5 (2H, d, J = 1 6Hz), 7. 78 (2H. s), 7 86 (4H, s), 9. 7 5 (211, s). 10. 68 (2H. S). Example 20

依同樣之方法,由(S)-3-第三丁氧羰基-1-氛甲基-5-羥 基-1,2-二氫吡咯並[3,2-3]叶唑14.91^(40«1〇〇义)與3,3· -(1,4 -伸笨基)二丙鋪酸 4.4mg(20w m〇A),取得 1.5mg( 10!〇之(3,3)-3,3’-[3,3’-(1,4-伸苯基)二丙烯醢基]雙-Π-氮甲基-5 -羥基-1,2 -二氫吡。各並[3,2-a]4唑]。 [« ] D28 = - 4 Γ e ( c = 0 . 05' 四氫呋喃 )In the same way, (S) -3-Third-butoxycarbonyl-1-aminomethyl-5-hydroxy-1,2-dihydropyrrolo [3,2-3] pyrazole 14.91 ^ (40 « 100%) and 4.4 mg (20w mOA) of 3,3 ·-(1,4-benzyl) dipropanoic acid to obtain 1.5mg (10,00 of (3,3) -3,3 '-[3,3'-(1,4-phenylene) dipropenylfluorenyl] bis-Π-nitromethyl-5 -hydroxy-1,2-dihydropyridine. Each of [3,2-a ] 4azole]. [«] D28 =-4 Γ e (c = 0.05 'tetrahydrofuran)

N M R ( D M S O d g) δ : 3. 83(21!. dd, J = 8 肩 11Hz), 3. 98-4. 05 (211, m). 4. 34-4. 4 2 (2H,tn), 4. 53-4. 64 (4H.m), 7. 18(ZH, t. J = TH2), 7. 34(ZH,d. J = 15Hz), 7. 39(2H .t. J = 7Hz). 7. 51 (2H. d, J = 7Hz). 7. 6 9(2H. d, J = 15IIz), 7. 90 (4H. s), 7. 91(211, d, J = 7!lz) ,8. 11(2H. s). 10. 08(2H, s). 11. 20(211, s). 實施例21 木紙悵尺度適用中罔同家標卒(CNS ) Λ4規格(2丨0X297公漦) _ΒΙ^1· m^i ^mf tm« i /f / m^i Huff n^i n^i· —^ϋ J US. Ί 矣 (請先閱讀背面之注意事項再填寫本頁) 35 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(:丨:3)NMR (DMSO dg) δ: 3.83 (21 !. dd, J = 8 shoulder 11Hz), 3. 98-4. 05 (211, m). 4. 34-4. 4 2 (2H, tn), 4. 53-4. 64 (4H.m), 7. 18 (ZH, t. J = TH2), 7. 34 (ZH, d. J = 15Hz), 7. 39 (2H.t. J = 7Hz ). 7. 51 (2H. D, J = 7Hz). 7. 6 9 (2H. D, J = 15IIz), 7. 90 (4H. S), 7. 91 (211, d, J = 7!) lz), 8. 11 (2H. s). 10. 08 (2H, s). 11. 20 (211, s). Example 21 The paper and paper scales are applicable to the standard Chinese standard (CNS) Λ4 specification ( 2 丨 0X297 公 漦) _ΒΙ ^ 1 · m ^ i ^ mf tm «i / f / m ^ i Huff n ^ in ^ i · — ^ ϋ J US. Ί 矣 (Please read the notes on the back before filling in this Page) 35 A7 B7 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs V. Invention Description (: 丨: 3)

依同樣之方法,由(S)-3 -第三丁氧羰基-1-氛甲基-5-羥 基-1,2,3,6 -四氫-比咯並[3,2-e]吲哚-8 -羧酸甲酯9.5mg (25w m〇A )與 3,3’-(1,4-伸苯基)二丙烯酸2.71^(12.5 w m〇A ),取得 2.8mg(30:C)之(5,5)-3,3'-[3,3’-(1,4-伸 苯基)二丙烯醚基]雙-[1-氛甲基-5 -羥基-1,2,3,6-四氫吡 咯並[3,2-e]吲哚-8-羧酸甲酯]。 Γ α 1 26=-8。 (c = 0.20、四氫呋哺 )In the same way, from (S) -3 -Third-butoxycarbonyl-1-aminomethyl-5-hydroxy-1,2,3,6-tetrahydro-pyrrolo [3,2-e] ind Indole-8-carboxylic acid methyl ester 9.5mg (25w mOA) and 3,3 '-(1,4-phenylene) diacrylic acid 2.71 ^ (12.5 wmOA), to obtain 2.8mg (30: C) Of (5,5) -3,3 '-[3,3'-(1,4-phenylene) dipropenyl ether] bis- [1-lanemethyl-5 -hydroxy-1,2,3 , 6-tetrahydropyrrolo [3,2-e] indole-8-carboxylic acid methyl ester]. Γ α 1 26 = -8. (C = 0.20, tetrahydrofuran)

L D NMR(DMS〇 d 6) δ : 3. 4 5-3. 5 8 ( 2 11, m), 3. 80(611. s), 3. 7 2-3. 88 ( 211, m). 3. 94(211, d, J = 8. 8Hz), -1. 31-4. 44 (211. m). 4. Ί8 (2H, d. J = 8. 8Hz). 7. 31 (2H. d, J = 15Hz), 7. 67(211. d, J = 15Hz), 7. 88(411, s), 7. 9 3(211. d, J = 2. 9Hz). 7. 9 7 (2H, brs). 10. Zl(2il. s). 1 2.03(2H. s). 實施例22LD NMR (DMS〇d 6) δ: 3.4 5-3. 5 8 (2 11, m), 3. 80 (611. s), 3. 7 2-3. 88 (211, m). 3 94 (211, d, J = 8. 8Hz), -1. 31-4. 44 (211. m). 4. Ί8 (2H, d. J = 8. 8Hz). 7. 31 (2H. D , J = 15Hz), 7. 67 (211. D, J = 15Hz), 7. 88 (411, s), 7. 9 3 (211. D, J = 2. 9Hz). 7. 9 7 (2H , brs). 10. Zl (2il. s). 1 2.03 (2H. s). Example 22

Me〇2〇Me〇2〇

木紙張尺度適用中阈罔家標準(CNS ) Λ4規格(210X297公f ) 訂 線 (請先閱讀背面之注意事項再填寫本頁) -36 - 經濟部中央標準局員工消费合作社印聚 A7 B7 五、發明説明(:l·}) 依同樣之方法,由(S)-3-第三丁氧羰基-1-氛甲基-5-羥 基-1,2,3,6-四氫》比咯並[3,2-6]吲哚-7-羧酸甲酯38.11〇8( ΙΟΟμ m〇A )與 3,3’-(1,4-伸笨基)二丙烯酸10.911^(50 « moil ),取得 2.2mg(6a;)之(5,$)-3,3'-[3,3'-(1,4-伸苯 基)二丙烯醃基]雙-[1-氛甲基-5-羥基-1,2,3,6 -四氫咁咯 並[3,2-e]吲哚-7 -羧酸甲酯]。 [a]D28=+21。 (c = 0. 05、四氫呋喃 ) N M R ( D M S Ο d J δ : 3. 87(611. s), 3. 90-3. 99 (2H. m), 4. 02-4. 16(4H. m), 4. 6 28-4. 37(2H, m). 4. 5 2-4. 6 3 ( 2H. m). 7. 26(211. d. J = 15Hz). 7. 22-7. 30 (2H. m)7. G6(2H, d .J = 15Hz). 7. 85(411, s). 7. 9 2(211, s). 9. 79(211. s), 11. 61(211. s). 參考例1Wood paper scale is applicable to the Mid-Threshold Home Standard (CNS) Λ4 specification (210X297 male f). (Please read the precautions on the back before filling out this page) 2. Description of the invention (: l ·)) According to the same method, from (S) -3-third butoxycarbonyl-1-aminomethyl-5-hydroxy-1,2,3,6-tetrahydro >> [3,2-6] Indole-7-carboxylic acid methyl ester 38.11〇8 (100 μm〇A) and 3,3 '-(1,4-benzyl) diacrylic acid 10.911 ^ (50 «moil) To obtain 2.2 mg (6a;) of (5, $)-3,3 '-[3,3'-(1,4-phenylene) dipropenyl] bis- [1-aeromethyl-5 -Hydroxy-1,2,3,6-tetrahydropyrrolo [3,2-e] indole-7-carboxylic acid methyl ester]. [a] D28 = + 21. (C = 0.05, tetrahydrofuran) NMR (DMS Ο d J δ: 3. 87 (611. S), 3. 90-3. 99 (2H. M), 4. 02-4. 16 (4H. M ), 4. 6 28-4. 37 (2H, m). 4. 5 2-4. 6 3 (2H. M). 7. 26 (211. D. J = 15Hz). 7. 22-7. 30 (2H.m) 7. G6 (2H, d.J = 15Hz). 7. 85 (411, s). 7. 9 2 (211, s). 9. 79 (211. S), 11. 61 (211. s). Reference Example 1

Tf〇-/~V〇Tf o 於萘醌 100mg(0.62mm〇il )中加人 10!«Pd/c lO.Omg與無水 四氫呋喃2ml ,於氫氣流下,室溫下攪拌2小時。冰冷下 ,加人2,4,6-三甲基咁啶0.4〇!!1义(3.03111111〇]1)與無水三氟 甲烷磺酸0.261^(1.55«1111〇又),於氤氣流下室溫下拽拌2小 時。將反應液過瀘,並餾除溶劑後,加人二氣甲烷,Μ水 、1Ν鹽酸、飽和食鹽水順次清洗並於無水硫酸納上乾燥。 餾除溶劑,Μ矽膠柱層析(己烷:醋酸乙醃= 10: 1)精製 ,可得78.7mg(30S;)之.無色油1,4 -雙- (((三氟甲基)磺釀) 氧基)萘。 本紙張尺度適用中國國家標率(CNS ) Λ4規格(210X 297公犛) — 裝 訂 線 (請先閱讀背面之注意事項再填寫本頁) -37 - 經濟部中央標準局員工消费合作社印裝 A7 B7 五、發明説明(:丨5) 高分解能質譜 M C i 2 H e H e 0 e S z 計算值:423. 95 1 0 實測值:423 . 95 1 2 參考例Tf0- / ~ VTfo was added to 100 mg (0.62 mm) of naphthoquinone, and 10! «Pd / c 10. 0 mg and 2 ml of anhydrous tetrahydrofuran were stirred under a hydrogen stream at room temperature for 2 hours. Under ice cooling, add 2,4,6-trimethylpyridine 0.4〇 !! 1 meaning (3.03111111〇] 1) and anhydrous trifluoromethanesulfonic acid 0.261 ^ (1.55 «1111〇 again), in the chamber under the radon air Stir at warm for 2 hours. The reaction solution was purged, and the solvent was distilled off. Then, digas methane was added, and M water, 1N hydrochloric acid, and saturated brine were successively washed and dried over anhydrous sodium sulfate. The solvent was distilled off, and the silica gel column chromatography (hexane: ethyl acetate = 10: 1) was purified to obtain 78.7 mg (30S;). Colorless oil 1,4-bis-(((trifluoromethyl) sulfonic acid) Stuffed) oxy) naphthalene. This paper size applies to China's National Standards (CNS) Λ4 specification (210X 297 cm) — binding line (please read the precautions on the back before filling out this page) -37-Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (: 丨 5) High resolution mass spectrum MC i 2 H e H e 0 e S z Calculated value: 423. 95 1 0 Found: 423. 95 1 2 Reference example

TfOTfO

OTf 依同樣之方法,由1,4-憩醌300mg(1.44mm〇A),取得 450mg(66!l!)l,4-雙- (((三氟甲基)磺酸)氧基)憩。 熔點 1 52.5-153. 元素分析 以C, 計算值:C, 40.51; Η, 1.70 實測值:C, 40.31; Η, 1.54 質譜 (m/z) : 474 (Μ + ) 參考例3In the same way, OTf obtained 450 mg (66! L!) Of 1,4-bis-(((trifluoromethyl) sulfonic acid) oxy) from 300 mg of 1,4-quinone (1.44 mmOA). . Melting point 1 52.5-153. Elemental analysis Based on C, Calculated: C, 40.51; Thallium, 1.70 Found: C, 40.31; Thallium, 1.54 Mass spectrum (m / z): 474 (Μ +) Reference Example 3

依同樣之方法,由5,8-二甲氧基禁醌50〇11^(2.29111111〇义) ,取得163mg(15:n之1,4-雙- (((三氟甲基)磺醢)氧基)-5 , 8 -二甲氧基禁。 本纸張尺庹適用中阀阀家標率(CNS ) Λ4規格(210X 297公蛴) I I I 、-^ (請先閱讀背面之注意事項再填寫本頁) 38 - A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(36) 熔點 1 45. 5-1 46. 5 TC 元素分析 MC14H1DFG〇BS2 計算值:C, 34.72; Η, 2.08 實測值:C, 34.88; Η, 1.82 質譜 (m/z) : 484 (Μ + ) 參考例2In the same way, 163 mg (15: n of 1,4-bis-(((trifluoromethyl) sulfonyl)) was obtained from 5,8-dimethoxyquinone 50〇11 ^ (2.29111111〇yi). Oxy) -5, 8-dimethoxy ban. This paper size is suitable for medium valve valve standard (CNS) Λ4 size (210X 297 cm) III,-^ (Please read the precautions on the back before (Fill in this page) 38-A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (36) Melting point 1 45. 5-1 46. 5 TC elemental analysis MC14H1DFG〇BS2 Calculated value: C, 34.72; Η, 2.08 Found: C, 34.88; Η, 1.82 Mass spectrum (m / z): 484 (Μ +) Reference example 2

Tf〇-^OT, MeO OMe 依同樣之方法,由2,3-二甲氧基苯醌10〇1^(0.59111111〇殳) ,取得218mg(84!n之1,4 -雙-((三氟甲基)硪醢)氧基)-2,3 -二甲氧基苯。 高分解能質譜 W C , Q H B F s 0 B S 2 計算值:433.9565 實測值:433.9564 參考例5Tf〇- ^ OT, MeO OMe According to the same method, from 2,3-dimethoxybenzoquinone 1001 ^ (0.59111111〇 殳), 218mg (84! N of 1,4-bis-((tri Fluoromethyl) i) oxy) -2,3-dimethoxybenzene. High resolution mass spectrum W C, Q H B F s 0 B S 2 Calculated value: 433.9565 Found value: 433.9564 Reference example 5

TfOTfO

依同樣之方法,由5,5 -二羥基-2,2'-二吡啶基280mg (l,49mm〇jl ),取得 567mg(84:n 之 5,5·-雙- (((三氟甲基) 硪醢)氧基)-2,2二吡啶基。 熔點 158.0-162.0Ό 本紙張尺度適用中國國家標率(CNS ) Λ4規格(210X297公簸) ----------裝—一-----訂------線 (請先閱讀背面之注意事項再填寫本頁) 39 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(:丨7) 元素分析 MClzHeFeN20BS2 計算值:C, 31.87 ; Η &gt; 1.34; Ν, 6.19 實測值·· C,31.72 : Η,1.14; Ν - 6.40 質譜 (m/z) : 452 (Μ + ) 參考例6In the same manner, 567 mg (84: n of 5,5 · -bis-(((trifluoromethyl))) was obtained from 280 mg (l, 49 mmOjl) of 5,5-dihydroxy-2,2'-dipyridyl. Base) 硪 醢) oxy) -2,2 dipyridyl. Melting point 158.0-162.0Ό This paper size is applicable to China National Standards (CNS) Λ4 specifications (210X297). — 一 ----- Order ------ line (please read the notes on the back before filling out this page) 39 A7 B7 printed by the Staff Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (: 丨 7) Elemental analysis MClzHeFeN20BS2 Calculated value: C, 31.87; Η &gt;1.34; Ν, 6.19 found · C, 31.72: Η, 1.14; Ν-6.40 Mass spectrum (m / z): 452 (Μ +) Reference Example 6

Et02C—^ CO,EtEt02C— ^ CO, Et

將1,4-雙-(((三氟甲基)磺醢)氧基)禁30.0mg(71/z moil )與三乙胺〇.〇41mil (0.29mm〇il )與丙烯酸乙酷0.16mA )與 1,3-二苯滕基丙烧 2.9mg(7.0w moil )與醋酸 鋇1.6mg(7.1«ni〇il)於無水二甲基甲醸胺5mA中懸浮並於 氬氛圍氣下80t:下攪拌一晚。加入二氯甲烷,K535鹽酸、 水、飽和食鹽水順次清洗,並於無水硫酸納上乾燥。餾除 溶劑,將所得之殘渣Μ矽膠柱層析(二氛甲烷:己烷=1: 1)精製*取得19.5mg(85;U)之黃色結晶3,3'-(1,4_萘二基) 二丙烯酸乙酯。1,4-Bis-(((trifluoromethyl) sulfofluorenyl) oxy) was banned from 30.0 mg (71 / z moil) with triethylamine 0.041 mil (0.29 mm) and ethyl acrylate 0.16 mA ), 2.9 mg (7.0w moil) of 1,3-diphenyltenyl propane and 1.6 mg (7.1 «niOl) of barium acetate were suspended in anhydrous dimethylformamide 5mA and 80t under argon atmosphere: Stir overnight. Dichloromethane was added, K535 hydrochloric acid, water and saturated brine were successively washed, and dried over anhydrous sodium sulfate. The solvent was distilled off, and the obtained residue was subjected to silica gel column chromatography (dichloromethane: hexane = 1: 1) and purified * to obtain 19.5 mg (85; U) of yellow crystals 3,3 '-(1,4_naphthalene di Based) ethyl diacrylate.

熔點 84 . 0-87 . 0 1CMelting point 84.0-87.0 1C

元素分析 M C 0 計算值:C, 74.06; Η, 6.21 實測值:C, 73.89; Η, 6.21 參考例7 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公簸) ----------------ΪΤ------.^ (請先閱讀背面之注意事項再填艿本頁) 40 A7 B7Elemental analysis MC 0 Calculated value: C, 74.06; Η, 6.21 Measured value: C, 73.89; Η, 6.21 Reference example 7 This paper size applies to the Chinese National Standard (CNS) Λ4 specification (210X 297 public dust) ----- ----------- ΪΤ ------. ^ (Please read the notes on the back before filling this page) 40 A7 B7

經濟部中央標準局員工消費合作社印製Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs

五、發明説明(38)V. Invention Description (38)

EtQ2C 依同樣之方法,由1,4 -雙-(((三氟甲基)硪醢)氧基)葱 300mg(0.63min〇il),取得 169mg(7U)之 3,3·-(1,4-憩二基 )二丙烯酸乙酯。 熔點 98 . 5-99.5 υ 元素分析 M CZ4H2Z0« 計算值:C, 76.99; Η, 5.92 實測值:C, 76.76; Η, 6.04 質譜 (m / z ) : 3 7 4 ( Μ + ) 參考例8EtQ2C In the same way, 300 mg (0.63 min) of 1,4-bis-(((trifluoromethyl) fluorene) oxy) onion was obtained to obtain 169 mg (7U) of 3,3 ·-(1, 4-Di-diyl) ethyl diacrylate. Melting point 98. 5-99.5 υ Elemental analysis M CZ4H2Z0 «Calculated: C, 76.99; Η, 5.92 Found: C, 76.76; Η, 6.04 Mass spectrum (m / z): 3 7 4 (Μ +) Reference Example 8

Et02C 依同樣之方法,由1,4 -雙- (((三氟甲基)硪醢)氧基 -9,10-二氫-9,1〇-二氧基愚10〇1118(0.2〇1111〇〇^{1),取得49.0 1^(61%)之3,3’-(9,10-二氫-9,10-二氧基-1,4-憩二基)二 丙烯酸乙酯。 熔點 222.5-224.5t 元素分析 M C2«H2()0b 本纸張尺度適用中國國家標準(CNS ) Λ4規格(2丨OX 297公釐) 裝 訂 線 (請先閲讀背面之注意事項再填寫本頁) -41 - 五、發明説明(:⑼ A7 B7 計算值:C, 71.28; H, 4.98 實測值:C , 71·09 ; Η , 4.93 質譜 (m/z) : 404 (Μ + ) 參考例9 sto2cEt02C In the same way, from 1,4-bis-(((trifluoromethyl) fluorene) oxy-9,10-dihydro-9,10-dioxybenzene 1001118 (0.2〇1111 〇〇 ^ {1), 49.0 1 ^ (61%) of 3,3 '-(9,10-dihydro-9,10-dioxy-1,4-cyclodiyl) diacrylate was obtained. Melting point 222.5-224.5t Elemental analysis M C2 «H2 () 0b This paper size is applicable to Chinese National Standard (CNS) Λ4 specification (2 丨 OX 297 mm) Gutter (please read the precautions on the back before filling this page) -41-V. Description of the invention (: ⑼ A7 B7 Calculated value: C, 71.28; H, 4.98 Found: C, 71 · 09; Η, 4.93 Mass spectrum (m / z): 404 (Μ +) Reference example 9 sto2c

MeO OMe co2et 依同樣之方法,由1,4 -雙-(((三氟甲基)磺豳)氧基)-5,8 -二甲氧基萘 300mg(0.62mni〇il) * 取得 219ng(92S!)之 3,3'-(5,8-二甲氧基-1,4-M二基)二丙烯酸乙酯。 熔點 1 19 . 0-122 . 0¾ 元素分析 K C22H240b 計算值:C, 68.74; Η, 6.29 實測值:C, 68.50: Η, 6.29 質譜 (m/z) : 384 (Μ + ) 參考例10 -------------裝—------訂------線--- (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製MeO OMe co2et According to the same method, 300 mg (0.62 mmol) of 1,4-bis-(((trifluoromethyl) sulfonyl) oxy) -5,8-dimethoxynaphthalene * was obtained 219ng ( 92S!) Ethyl 3,3 '-(5,8-dimethoxy-1,4-Mdiyl) diacrylate. Melting point 1 19. 0-122. 0¾ Elemental analysis K C22H240b Calculated value: C, 68.74; Er, 6.29 Found: C, 68.50: Er, 6.29 Mass spectrum (m / z): 384 (Μ +) Reference example 10- ----------- install ------- order ------ line --- (Please read the precautions on the back before filling out this page) Staff Consumption of the Central Standards Bureau of the Ministry of Economic Affairs Printed by a cooperative

Et02CEt02C

CO2B 依同樣之方法,由5,5 ’-(1,4-雙- (((三氟甲基)磺豳)氧 基))-2,2'-二 捉基 83.2mg(0.18mm〇A ),.取得 54.3mg (8430之3,3|-(2,2’-二吡啶基-5, 5’-二基)二丙烯酸乙酯。 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) -42 - 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(:! 0) , 熔點 1 7 3 . 5- 1 7 5 . OTC 元素分析 W C 2 n H 2 D H z 0 4 計算值:C* 68.17; Η, 5.72; N, 7.95 實測值:C, 67,89; Η, 5.64; N, 7.93 質譜 U/z) : 35 2 (Μ + ) 參考例11 ε,〇2〇ά_^~^γ C〇zEtIn the same way, CO2B was prepared from 5,5 '-(1,4-bis-(((trifluoromethyl) sulfonyl) oxy))-2,2'-dicaryl 83.2mg (0.18mm〇A). ), 54.3mg (8430 of 3,3 |-(2,2'-dipyridyl-5, 5'-diyl) ethyl diacrylate. This paper size applies the Chinese National Standard (CNS) Λ4 specification ( 210X297 mm) -42-Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (:! 0), melting point 1 7 3. 5- 1 7 5. OTC elemental analysis WC 2 n H 2 DH z 0 4 Calculated: C * 68.17; Η, 5.72; N, 7.95 Found: C, 67,89; Η, 5.64; N, 7.93 Mass spectrum U / z): 35 2 (Μ +) Reference Example 11 ε, 〇 2〇ά_ ^ ~ ^ γ C〇zEt

MeO 〇Me 將1,4-雙- (((三氟甲基)磺醯)氧基)-2,3-二甲氧基苯 200rag(0.46mmojl )與氯化鍾 58.5mg(1.38mmoJl )懸浮於無 水二甲基甲醯胺2.3mA中,於吹入氬氣脫氣後,加入二f 化雙(三苯膦)鈀16.1mg(23^〇il )並於lOOt:下攪拌30分鐘 。續加人3-(三丁基甲錫烷基)丙烯酸乙酯537mg(1.38mm〇il )之無水二甲基醢胺0.5mA溶液,於100t:下攪拌30分鐘。 加入二氯甲烷,Μ水、5%氟化鉀順次清洗,並K無水硫酸 納乾燥。餾除溶劑,將所得之殘渣Μ矽膠柱層析(醋酸乙 酯:己烷=1:6)精製,取得18.61^(145〇之無色稜晶3,3’ -(2,3 -二甲氧基-1,4 -伸笨基)二丙烯酸乙酯。 熔點 88 . 5 -8 9 . 5 1C 元素分析 MC10H22Ob 計算值:C, 64.66; Η, 6.63 實測值:C, 64.45; Η, 6.66 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) 一 4 3 一 I 裝 訂 線 (請先閱讀背面之注意事項再填寫本頁) A7 B7 經濟部中央標準局員工消費合作社印製MeO 〇Me Suspended 1,4-bis-(((trifluoromethyl) sulfonyl) oxy) -2,3-dimethoxybenzene 200rag (0.46mmojl) and 58.5mg (1.38mmoJl) chloride In 2.3 mA of anhydrous dimethylformamide, after degassing by blowing in argon, 16.1 mg (23 mg) of bis (triphenylphosphine) palladium difluoride was added and stirred for 30 minutes at 100 t :. A solution of 537 mg (1.38 mm) of ethyl 3- (tributylmethylstannyl) acrylate in anhydrous dimethylamidine 0.5 mA was added, and the mixture was stirred at 100 t for 30 minutes. Dichloromethane was added, M water, 5% potassium fluoride were successively washed, and dried over anhydrous sodium sulfate. The solvent was distilled off, and the obtained residue was purified by silica gel column chromatography (ethyl acetate: hexane = 1: 6) to obtain 18.61 ^ (145 ° of colorless prisms 3,3 '-(2,3-dimethoxy). -1,4-dibenzyl) ethyl diacrylate. Melting point 88. 5 -8 9. 5 1C Elemental analysis MC10H22Ob Calculated value: C, 64.66; Η, 6.63 Found: C, 64.45; Η, 6.66 paper Standards apply to Chinese National Standards (CNS) Λ4 specifications (210X 297 mm) One 4 3 One I gutter (please read the precautions on the back before filling this page) A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

五、發明説明UJL) 質譜 U/Z) : 334 (M + ) 參考例12V. Description of the invention UJL) Mass spectrum U / Z): 334 (M +) Reference example 12

H02C 將 3,3’_(1,4-M 二基)二丙烯酸乙酯 115mg(0.35mmoil ) 與氫氧化鉀196mg(3.49mm〇il)溶解於乙酵2mA中並迴流2 小時。加入1 N鹽酸使p Η = 1,析出之结晶Μ水、乙酵順次 清洗,乾燥可得90.2mg(95!U)之3,3’-(1,4-萘二基)二丙烯 酸。 熔點 350 . 0 -3 5 5 . 0 1C 高分解能質譜 M C i β H i 2 0 4 計算值:268.0736 實測值:268.0743 參考例13 厂 co2h 依同樣之方法,由3,3 ’- (1,4 -憩二基)二丙烯酸乙酯200 1^(0.53111111〇]1),取得15211^(89:«)之3,3’-(1,4-憩二基)二 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) ----------裝—-----ΐτ------.^ (請先閱讀背面之注意事項再填寫本頁) 44 - 經濟部中央標隼局員工消費合作社印製 A7 B7 五、發明#明(42) 丙烯酸。 熔點 328.5-338.Ot: Θ 韧〉 高分解能質譜 M C 2 D H i « 0 &lt; 計算值:3 1 8 . 0 8 9 2 實測值:318.0894 參考例14H02C 115 mg (0.35 mmoil) of ethyl 3,3 '_ (1,4-M diyl) diacrylate and 196 mg (3.49 mm) of potassium hydroxide were dissolved in acetic acid 2 mA and refluxed for 2 hours. 1 N hydrochloric acid was added to make p Η = 1, and the precipitated crystal water and acetic acid were sequentially washed and dried to obtain 90.2 mg (95! U) of 3,3 '-(1,4-naphthalenediyl) diacrylic acid. Melting point 350. 0 -3 5 5. 0 1C High resolution energy mass spectrum MC i β H i 2 0 4 Calculated value: 268.0736 Found value: 268.0743 Reference example 13 Plant co2h According to the same method, from 3,3 '-(1,4 -Xijiji) Ethyl diacrylate 200 1 ^ (0.53111111〇] 1), 3152 '^ (89: «) 3,3'-(1,4-Xijiji) two paper sizes are applicable to Chinese national standards (CNS) Λ4 specification (210X 297 mm) ---------- installation ------- ΐτ ------. ^ (Please read the precautions on the back before filling this page) 44-Printing of A7 B7 by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs V. Invention # 明 (42) Acrylic acid. Melting point 328.5-338.Ot: Θ toughness> High resolution energy mass spectrum M C 2 D H i «0 &lt; Calculated value: 3 1 8. 0 8 9 2 Found: 318.0894 Reference example 14

依同樣之方法,由3,3’-(9,10 -二氫-9,10 -二氧基-1,4-憩二基)二丙烯酸乙酯250〇^(0.621!1111〇义),取得2151118:(100 %)之 3, 3’-(9,10-二氣-9,10-二氧基-1,4-爵二基)二丙稀 酸。 熔點 323.0-338.Ot: 岵) 元素分析 M C2aH120s 計算值:C, 68.97; Η, 3.47 實測值:C, 68.71; Η, 3.31 參考例15 裝 訂 線 (請先閱讀背面之注意事項再填寫本頁)In the same way, from 3,3 '-(9,10-dihydro-9,10-dioxy-1,4-cyclodiyl) diacrylate 250〇 ^ (0.621! 1111〇), Obtained 2151118: (100%) of 3,3 '-(9,10-digas-9,10-dioxy-1,4-diphenyl) dipropionic acid. Melting point 323.0-338.Ot: 岵) Elemental analysis M C2aH120s Calculated value: C, 68.97; Η, 3.47 Measured value: C, 68.71; Η, 3.31 Reference example 15 Gutter (Please read the precautions on the back before filling this page )

本紙張尺度適闵中國國家標準(CNS ) Λ4規格(210Χ 297公釐) 45 _ &gt;1 I; _ 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(U) 依同樣之方法,由3,3'-(5,8-二甲氧基-1,4-荼二基)二 丙烯酸甲酿 100mg(0.26mm〇il ),取得 79.5mg(93!K)之 3,3·-(5,8 -二甲氧基_1,4 -禁二基)二丙稀酸。 熔點 290 . 0-299 . 5 υ (分解) 高分解能質譜 MC1BH1S0B 計算值:327.0864 實測值:327.0934 參考例1 6The size of this paper is suitable for China National Standard (CNS) Λ4 specification (210 × 297 mm) 45 _ &gt; 1 I; _ Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (U) According to the same method 100 mg (0.26 mm) of 3,3 '-(5,8-dimethoxy-1,4-diadiyl) diacrylate was obtained from 3,3'-(5,8-dimethoxy-1,4-diadiyl) diacrylate to obtain 39.5 of 79.5 mg (93! K) -(5,8-dimethoxy-1,4-diphenyl) dipropionic acid. Melting point 290. 0-299. 5 υ (decomposition) High resolution mass spectrum MC1BH1S0B Calculated value: 327.0864 Found value: 327.0934 Reference example 1 6

h〇2Cav_^v^-/ac〇2H 依同樣之方法*由3,3'-(2,2'-二咁啶基-5,5 -二基)二 丙烯酸乙酯 100mg(0.28mm〇A ),取得 73.8ms(88S:)之 3,3'-(2, 2’-二吡啶基-5,5’-二基)二丙烯酸。 熔點 447.0-454. 0 ICC々高翠) 髙分解能質譜 M C , s H i 2 N 2 計算值:2 9 7 . 0 8 7 5 實測值:297.0875 參考例17h〇2Cav_ ^ v ^-/ ac〇2H According to the same method * from 3,3 '-(2,2'-diamidinyl-5,5-diyl) ethyl diacrylate 100mg (0.28mm〇A) ) To obtain 73.8ms (88S :) of 3,3 '-(2, 2'-dipyridyl-5,5'-diyl) diacrylic acid. Melting point 447.0-454. 0 ICC (Gao Cui) 髙 Decomposition energy mass spectrum M C, s H i 2 N 2 Calculated value: 2 9 7. 0 8 7 5 Found: 297.0875 Reference Example 17

MeO OMe 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) _ — 裝 —訂 線 (請先閲讀背面之注意事項再填寫本頁) 46 經濟部中央標準局員工消f合作社印製 A7 B7 五、發明説明(个j) 依同樣之方法,由3,3 ’- (2,3 -二甲氧基-1,4 -伸笨基)二 丙烯酸乙酿 44.5mg(0.13mm〇il ),取得 36.3mg:(98!l:)之 3,3’ -(2,3 -二甲氧基-1,4 -伸苯基)二丙烯酸。 熔點 304.0-315. 5 ¾ (分解) 高分解能質譜 MC^HhOb 計算值:278.0790 實測值:278.0802 參考例18 ho2cMeO OMe This paper size is applicable to Chinese National Standard (CNS) Λ4 specification (210X297mm) _ — Binding — Thread (please read the precautions on the back before filling this page) 46 Printed by the staff of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (a) According to the same method, 44.5 mg (0.13 mm) of 3,3 '-(2,3-dimethoxy-1,4-benzyl) diacrylate was prepared from ethyl diacrylate. ) To obtain 36.3 mg: (98! L :) of 3,3 '-(2,3-dimethoxy-1,4-phenylene) diacrylic acid. Melting point 304.0-315. 5 ¾ (decomposition) High resolution mass spectrum MC ^ HhOb Calculated value: 278.0790 Found value: 278.0802 Reference example 18 ho2c

co2h 依同樣之方法,由3,3 ’- (9, 10 -憩二基)二丙烯酸乙酯 200mg(0.53mm〇il ),取得 161mg(963〇 之 3,3'-(9,1〇 -葱二 基)二丙烯酸。 熔點 310. 5-31? . OTC (分解) 高分解能質譜 M C 2 D Η , 4 計算值:318.0892 實測值:3 1 8 . 0 9 1 5 參考例19 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公资) ----------^ ------ir---------- (请先閲讀背面之注意事項再填寫本頁) -47 - A7 B7 經濟郎中央標準局負工消资合作社印聚 五、發明説明(4 5) OHC-^ ^-CHO MeO OMe 於氫化雙(2-甲氧乙氧基)鋁納(70¾甲笨溶液)13.6g( 47.1111111〇义)中加人^-甲基六氫吡啩5,20克(51.9111111〇义) 之無水甲苯23mA溶液,調製試劑。將2,3-二甲氧基-1,4-苯二羧酸甲酯3.00克(11.8mm〇A )溶解於無水甲苯120mA 中,並將上述試劑於一邊保持於-20〜-171下一邊加入後 ,攪拌10分鐘。於反應液中加水除去不溶物後,以1N鹽酸 、水、飽和食鹽水順次清洗,並於無水硫酸納上乾燥。將 溶劑餾除,以矽膠柱層析(二氯甲烷)精製,取得1.84克 (80¾)之無色結晶2,3 -二甲氧基-1,4 -苯二羧基醛。 熔點 99.5-1 00.5 Ό 元素分析 以C : DH i。0&lt; 計算值:C, 61.85; Η, 5.19 實測值:C, 61.74; Η, 5.18 質譜 (m/z) : 194(Μ + ) 參考例20 OHC-^^-CHO Ο Ο 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) _ —I 訂 . 線 (請先閱讀背面之注意事項再填寫本頁) 48 經濟部中央標準局員工消费合作社印製 Λ7 B7 五、發明説明(·Η;) 依同樣之方法,由2, 3-(乙二氧基)-1, 4-笨二羧酸甲酯 3.00克(11.9|11111〇;1),取得371|118(16»:)之2,3-(乙二氣基 )-1 , 4-笨二羧基醛。 熔點 139.0-140.5t: 元素分析 M C i aH B0« 計算值:C, 62.50; Η, 4.20 實測值:C, 62.47; Η, 4.26 質譜 (m/z) : 192(Μ + ) 參考例21co2h According to the same method, 161 mg (963, 3, 3 '-(9, 1〇-) of 3,3'-(9, 10-diethyl) diacrylate, 200 mg (0.53 mm) was obtained in the same way. Onion diyl) diacrylic acid. Melting point 310. 5-31?. OTC (decomposition) High decomposition energy mass spectrum MC 2 D Η, 4 Calculated value: 318.0892 Found: 3 1 8. 0 9 1 5 Reference example 19 This paper applies to the standard China National Standard (CNS) Λ4 specification (210X297 public capital) ---------- ^ ------ ir ---------- (Please read the precautions on the back before (Fill in this page) -47-A7 B7 Jiro Lang Central Standards Bureau, Consumers and Consumers Cooperatives, Printing and Printing Co., Ltd. 5. Description of Invention (4 5) OHC- ^ ^ -CHO MeO OMe in hydrogenated bis (2-methoxyethoxy) aluminum Sodium (70¾ methylbenzyl solution) 13.6g (47.1111111〇yi) added ^ -methylhexahydropyridine 5,20 g (51.9111111〇yi) of anhydrous toluene 23mA solution to prepare the reagent. 2,3-dimethyl 3.00 g (11.8 mmOA) of methyl oxy-1,4-benzenedicarboxylate was dissolved in 120 mA of anhydrous toluene, and the above reagent was added while keeping it at -20 to -171, followed by stirring for 10 minutes. Water was added to the reaction solution to remove insoluble matters, and then 1N hydrochloric acid and water Saturated saline solution was successively washed and dried over anhydrous sodium sulfate. The solvent was distilled off and purified by silica gel column chromatography (dichloromethane) to obtain 1.84 g (80¾) of colorless crystals 2,3-dimethoxy- 1,4-Benzenedicarboxylic aldehyde. Melting point 99.5-1 00.5 Ό Elemental analysis is C: DH i. 0 &lt; Calculated value: C, 61.85; Η, 5.19 Found: C, 61.74; Η, 5.18 Mass spectrum (m / z ): 194 (Μ +) Reference Example 20 OHC-^^-CHO Ο Ο This paper size applies the Chinese National Standard (CNS) Λ4 specification (210X297 mm) _ — I order. Line (Please read the precautions on the back first (Fill in this page) 48 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Λ7 B7 V. Description of the invention (· Η;) In the same way, 2,3- (ethylenedioxy) -1,4-benzyldicarboxylate Methyl ester 3.00 g (11.9 | 11111〇; 1) to obtain 371 | 118 (16 »:) 2,3- (ethylenediamino) -1,4-benzyldicarboxyaldehyde. Melting point 139.0-140.5t: Elemental analysis MC i aH B0 «Calculated value: C, 62.50; Η, 4.20 Found: C, 62.47; Η, 4.26 Mass spectrum (m / z): 192 (Μ +) Reference example 21

OHC-H^^-CHO 依同樣之方法,由2, 3-(甲二氧基)-1,4 -苯二羧酸甲酯 3.00g(12.6mm〇il),取得 1.52g(683:)之 2,3-(甲二氧基 )-1 , 4-苯二羧基醛。OHC-H ^^-CHO According to the same method, 1.52 g (683 :) of 2,3- (methyldioxy) -1,4-benzenedicarboxylic acid methyl ester 3.00 g (12.6 mm) was obtained. 2,3- (methyldioxy) -1,4-benzenedicarboxyaldehyde.

熔點 151.5-152.0°C 元素分析 W C s H s (U 計算值:C, 60.68; Η, 3.39 實測值:C, 60.59; Η, 3.40 質譜 (π/ζ) : 178 (Μ + ) 參考例2 2 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210Χ2&lt;Π公犛) I ' ~.. 訂 I 線 (請先閲讀背面之注意事項再填寫本頁) 49 五、發明祝明(47) Η〇2〇—Melting point 151.5-152.0 ° C Elemental analysis WC s H s (U Calculated value: C, 60.68; Europium, 3.39 Found: C, 60.59; Europium, 3.40 Mass spectrum (π / ζ): 178 (Μ +) Reference example 2 2 This paper size is applicable to Chinese National Standard (CNS) Λ4 specification (210 × 2 &lt; Π 公 牦) I '~ .. Order I line (please read the precautions on the back before filling this page) 49 V. Inventive wishes (47) Η〇2〇-

MeO OMe Λ7 B7 co2h 將2,3-二甲氧基-1,4-笨二羧基醛1.0(^(5.15111111〇]1)與 丙二酸2.37以22.8|11111〇]1)與六氳咁啶0.1111]1與|1比啶7.〇111艾 之懸浮液迴流16小時。將反應液冰冷,並加入IN鹽酸使圼 PH=2。滹取析出之結晶,以水、乙醇、二氛甲烷順次清 洗。取得1.348(943!)無色結晶之3,3’-(2,3-二甲氧基-1,4 -伸苯基)二丙烯酸。 參考例2 3 ho2cMeO OMe Λ7 B7 co2h will be 2,3-dimethoxy-1,4-benzyldicarboxyaldehyde 1.0 (^ (5.15111111〇) 1) and malonic acid 2.37 to 22.8 | 11111〇] 1) and hexamidine The suspension of 0.1111] 1 and | 1 ratio pyridine 7.〇111 ai was refluxed for 16 hours. The reaction solution was ice-cooled, and IN hydrochloric acid was added so that pH = 2.析 Collect the precipitated crystals and wash them with water, ethanol, and dichloromethane successively. 3,3 '-(2,3-dimethoxy-1,4-phenylene) diacrylic acid was obtained as 1.348 (943!) Colorless crystals. Reference example 2 3 ho2c

厂 co2h I 訂 線 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消费合作社印製 依同樣之方法,由2,3-(乙二氧基)-1,4-苯二羧基醛 1.018(5.26111111〇义),取得1.398(96!〇之3,3’-(2,3-(乙 氧基)-1,4-伸苯基)二丙烯酸。 熔點 344.5-348.5 °C 高分解能質譜 C i 4 H i z 0 6 計算值:276.0634 實測值:276.0634 參考例24_ _ C Λ _ 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) 50 A7 B7Factory co2h I order (please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, the same method is used for 2,3- (ethylenedioxy) -1,4-benzene Dicarboxylic aldehyde 1.018 (5.26111111 〇 meaning), obtain 1.398 (96, 〇 3,3 '-(2,3- (ethoxy) -1,4-phenylene) diacrylic acid. Melting point 344.5-348.5 ° C High resolution energy mass spectrum C i 4 H iz 0 6 Calculated value: 276.0634 Measured value: 276.0634 Reference example 24_ _ C Λ _ This paper size applies to the Chinese National Standard (CNS) Λ4 specification (210X297 mm) 50 A7 B7

co2h Ο. .0 ho2cco2h Ο. .0 ho2c

Et Et 五、發明説明(‘1S) ho2c 依同樣之方法,由2,3-(甲二氧基)-1,4-笨二羧基醛 1.0〇8(5.61111111〇]1),取得1.398(94»:)之3,3’-(2,3-(甲二氧 基)-1 , 4 -伸苯基)二丙烯酸。 熔點 334. 0-338. 0 T: 高分解能質體 C13H1D0B 計算值:262.0477 實測值:2 6 2 . 0 4 6 2 參考例25 co2h 依同樣之方法*由2,3 -二乙基-1,4 -苯二羧基醛59.8rag (0.31mm〇il ),取得 62.6g(74;n 之 3,3'-(2,3-二乙基-1,4 伸苯基)二丙烯酸。 熔點 26 4 . 0-268 . 0 ¾ (分解) 高分解能質譜 計算值:274.1205 本紙張尺度適用中國國家標苹(CNS ) Λ4規格(210X297公梦) --------------裝------訂------線—- (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消費合作社印製 51 Λ7 B7 五、發明説明(1!« 實測值:274.1160 參考例26Et Et 5. Description of the invention ('1S) ho2c In the same way, from 2,3- (methyldioxy) -1,4-benzyldicarboxylic aldehyde 1.0008 (5.61111111〇) 1), 1.398 (94 »:) of 3,3 '-(2,3- (methyldioxy) -1, 4-phenylene) diacrylic acid. Melting point 334.0-338. 0 T: High decomposition energy mass C13H1D0B Calculated value: 262.0477 Found value: 2 6 2. 0 4 6 2 Reference example 25 co2h In the same way * from 2,3 -diethyl-1, 4-Benzenedicarboxylic aldehyde 59.8rag (0.31mm), to obtain 62.6g (74; n of 3,3 '-(2,3-diethyl-1,4 phenylene) diacrylic acid. Melting point 26 4 0-268. 0 ¾ (Decomposition) Calculated value of high resolution energy mass spectrum: 274.1205 This paper size is applicable to China National Standard Apple (CNS) Λ4 specification (210X297 public dream) -------------- installation ------ Order ------ Line --- (Please read the notes on the back before filling out this page) Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 51 Λ7 B7 V. Description of the invention (1! «Found: 274.1160 Reference Example 26

H〇2CH〇2C

co2hco2h

依同樣之方法,由(1,1’; 4,4”-聯三苯)-4,4”-二羧基 醛 80.0mg(0.28mm〇il),取得 96.4g(93S!)之3,3’-(4,4”-(1,1’ : 4·,4” -聯三苯))二丙烯酸。 熔點 340.0-345.0 °C 元素分析 W C 2 4 H t B 0 4 計算值:C,7 7 . 8 2 ; Η .39 實測值:C, 77.72; Η, 5,10 參考例27 ---------裝-------訂------線_” (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消費合作社印製According to the same method, (1,1 '; 4,4 ”-bitriphenyl) -4,4” -dicarboxyaldehyde 80.0 mg (0.28 mm), to obtain 96.4 g (93S!) Of 3,3 '-(4,4 ”-(1,1': 4 ·, 4” -bitriphenyl)) diacrylic acid. Melting point 340.0-345.0 ° C Elemental analysis WC 2 4 H t B 0 4 Calculated value: C, 7 7. 8 2; Η .39 Found: C, 77.72; Η, 5,10 Reference Example 27 ----- ---- install ------- order ------ line_ "(Please read the precautions on the back before filling this page) Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

H02CH02C

οο2η&gt; 依同樣之方法,由(1,1 ’ : 4 ’,4”-聯三苯)-3, 3”-二羧基 醛 859!^(3.00«1111〇1),取得1.068(95!1:)之3,3'-(3,3”-(1 , 1 ’ : 4 ’,4”-聯三笨))二丙烯酸。 熔點 337 . 0-343 . 0 Ό 高分解能質譜 以C ^ 4 H t 7 0 4 本纸張尺度適用中阀阀家標卒(CNS ) Λ4規格(210XM7公犛) -52 - A7 B7 五、發明説明(5()) 計算值:3 6 9 . 1 1 2 7 實測值:369 . 1 2 1 4 參考例28οο2η &gt; In the same way, from (1,1 ′: 4 ′, 4 ”-bitriphenyl) -3, 3” -dicarboxyaldehyde 859! ^ (3.00 «1111〇1), 1.068 (95! 1 :) of 3,3 '-(3,3 "-(1, 1': 4 ', 4" -liansanben)) diacrylic acid. Melting point 337. 0-343. 0 Ό High resolution energy mass spectrometry with C ^ 4 H t 7 0 4 This paper size is applicable to the valve standard (CNS) Λ4 specification (210XM7 male) -52-A7 B7 V. Invention Explanation (5 ()) Calculated value: 3 6 9. 1 1 2 7 Found: 369. 1 2 1 4 Reference example 28

Me〇2〇—(( '^~C〇2Mr MeO OMe 將2,3-二羥基-1,4-苯二羧酸甲酯5.〇(^(22.110111〇;1)溶 解於無水二甲基甲醢胺50mil中,加入碳酸筢17.3g(53.1 mnioil),於氬氛圍氣下室溫下攪拌30分鐘。加入甲基碘 3.31mA (53.2^01 ),並於室溫下撹拌2小時。將反應液 減壓濃縮,加入二氯甲烷,以水、飽和食鹽水順次清洗, 於無水硫酸納上乾燥。將溶劑餾除取得5.55g(99Si)茶色油 之2 , 3 甲氧基-1,4 -苯二羧酸甲酯 質譜 (m / z ) : 2 5 4 ( Μ + ) 參考例29 ----------------裝------訂------線I 一. (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製Me〇2〇 — ((^ ~ C〇2Mr MeO OMe dissolves methyl 2,3-dihydroxy-1,4-benzenedicarboxylate 5.0 (^ (22.110111〇; 1) in anhydrous dimethyl In 50 mil formamidine, 17.3 g (53.1 mnioil) of europium carbonate was added, and the mixture was stirred at room temperature under an argon atmosphere for 30 minutes. Methyl iodide 3.31 mA (53.2 ^ 01) was added and stirred at room temperature for 2 hours. The reaction solution was concentrated under reduced pressure, dichloromethane was added, and the mixture was sequentially washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off to obtain 5.55 g (99Si) of brown oil 2,3 methoxy-1,4. -Methylbenzenedicarboxylate mass spectrum (m / z): 2 5 4 (Μ +) Reference example 29 ---------------- 装 -------- Order-- ---- Line I. (Please read the notes on the back before filling out this page) Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

MeO?Cc〇2Me 0 Ο 依同樣之方法,由2,3 -二羥基-1,4 -苯二羧酸甲酯5.00g (22.1mnioJl ),取得 5.548(99¾)之 2,3-(乙二氧基)-1,4 -苯 本紙張尺度適用中國國家標準(CNS-) Λ4規格(210X 297公釐) 53 - 經濟部中央標準局員工消费合作社印製 A7 B7 五、發明説明(51) 二羧酸甲酯。 熔點 107, 5-110. ου 質譜 (m/z) : 25 2 (Μ + ) 參考例30MeO? Cc〇2Me 0 〇 According to the same method, from 2,5.00-dihydroxy-1,4-benzenedicarboxylic acid methyl ester 5.00g (22.1mnioJl), 5.548 (99¾) of 2,3- (ethylene Oxygen) -1,4-Benzene paper size applies Chinese National Standard (CNS-) Λ4 specification (210X 297 mm) 53-Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (51) 2 Methyl carboxylate. Melting point 107, 5-110. Ου Mass spectrum (m / z): 25 2 (Μ +) Reference example 30

MeQ2C—CQ2Me °v/° 依同樣之方法,由2,3 -二羥基-1,4 -苯二羧酸甲酯5.00 g(22.1nm〇jl),取得 5.14g(98!U 之 2,3-(甲二氧基)1,4-笨 二羧酸甲酯。 熔點 208 . 0-2 1 0 . 0 1C 質譜’(m/z):238(M+) 參考例3 1MeQ2C—CQ2Me ° v / ° According to the same method, from 5.00 g (22.1nm〇jl) of 2,3-dihydroxy-1,4-benzenedicarboxylic acid methyl ester, 5.14g (98! U of 2,3 -(Methyldioxy) 1,4-benzyl dicarboxylic acid. Melting point 208.0 0-2 1 0. 0 1C Mass spectrum '(m / z): 238 (M +) Reference example 3 1

將2-胺基-2-甲基-1-丙醇6.06g(68.0mm〇il )溶解於無水 二氛甲烷8mil中,將2,3-二甲氧基-1,4-苯二羧酸氛4.47g (17.0ιππι〇Α)之無水二氯甲烷8mil溶液一邊保持於内溫 5-10TC —邊加入後,於室溫下攪拌2小時。將反應液過濾 ,以水清洗後,將滹液與洗液合併並減壓澹縮。於所得殘 本紙張尺度適用中國國家標準(CNS ) Λ4現格(210Χ297公绛) ' -54 - -------------^------1Τ------^1' (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消费合作社印裝 A7 B7 五、發明説明(5.?) 渣中加入二氯甲烷,並於無水硫酸納上乾燥。將溶劑豳除 並經苯再结晶,取得6.27g(10〇m無色稜晶之Ν,Ν'-雙-(2-羥基-1,1-二甲基乙基)-2,3 -二甲氧基-1,4 -伸苯二羧基醢 胺。 熔點 151 . 0-153 . Ot 元素分析 K C, BH2BN20e 計算值:C, 58.68; Η, 7.66; N, 7.60 實測值:C, 58.65 ; Η * 7.79; Ν, 7.44 質譜 (m/z) : 36 8 (Μ + ) 參考例326.06 g (68.0 mm) of 2-amino-2-methyl-1-propanol was dissolved in 8 mil of anhydrous dichloromethane, and 2,3-dimethoxy-1,4-benzenedicarboxylic acid was dissolved. An 8 ml solution of anhydrous dichloromethane with an atmosphere of 4.47 g (17.0 μπιι ΑΑ) was kept at an internal temperature of 5-10 TC. After the addition, the mixture was stirred at room temperature for 2 hours. The reaction solution was filtered and washed with water, and then the mash and the washing solution were combined and shrunk under reduced pressure. Applicable to China National Standards (CNS) Λ4 Appearance (210 × 297 cm) at the size of the obtained scrap paper '-54-------------- ^ ------ 1Τ ---- -^ 1 '(Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Central Bureau of Standards, Ministry of Economic Affairs, printed A7 B7 V. Description of the invention (5.?) Dichloromethane is added to the slag, and anhydrous sulfuric acid is added. Let it dry. The solvent was decanted and recrystallized from benzene to obtain 6.27 g (100 m of colorless prisms of N, N'-bis- (2-hydroxy-1,1-dimethylethyl) -2,3-dimethylformaldehyde. Oxy-1,4-phenylenedicarboxylic acid amine. Melting point 151.0-153. Ot Elemental analysis KC, BH2BN20e Calculated value: C, 58.68; Η, 7.66; N, 7.60 Found: C, 58.65; Η * 7.79; Ν, 7.44 Mass spectrum (m / z): 36 8 (Μ +) Reference example 32

MeO OMe 於Ν’-雙- (2-羥基-1,1-二甲基乙基)-2,3-二甲氧基 -1,4-伸苯二羧基醢胺6.00g(16.3mnI〇il )中加人亞硫醢氯 7.0mA (96. OmmoA ),並於室溫下搜伴3小時後*再加入亞 碲醜氣7.0mA (96.0mm〇il),於室溫下攪拌1小時。將反應 液注入醚50mil中,上澄液Μ傾析除去,於殘渣中加入水 、10¾氫氧化納水溶液使ρΗ=8後| Κ醚萃取,於無水硫酸 納上乾煉。將溶劑餾除,殘渣Μ矽膠柱層析(二氛甲烷: 乙酵= 20: 1)精製,取得2.52g(47!«)無色結晶之2,2'-(2, 3-二甲氧基-1,4 -伸苯基)雙- (4,4-二甲基-2 -啤唑啉)。 本紙張尺度適用中國國家標準(CNS ) Λ4規格(2I0X297公釐) ---------^ -裝-------訂------Μ--„---1 (請先閱讀背面之注意事項再填寫本頁) -55 - 經濟郎中央標準局貝工消費合作社印製 A7 B7 五、發明説明(5 :j) 熔點 84 . 5-85 . 5 t: 元素分析 MC1BH24N2〇4 計算值:C, 65.04; Η, 7.28; N, 8.43 實測值:C, 64.96 ; Η · 7.16; Ν, 8.41 質譜 (m/Z) : 3 32 (Μ + ) 參考例33MeO OMe in N'-bis- (2-hydroxy-1,1-dimethylethyl) -2,3-dimethoxy-1,4-phenylenedicarboxylic acid amine 6.00g (16.3mnIol ) 7.0mA (96. OmmoA) of human thionyl chloride, and search at room temperature for 3 hours * and then add 7.0mA (96.0mm) tellurium gas, and stir at room temperature for 1 hour. The reaction solution was poured into 50 mils of ether, and the supernatant solution M was decanted and removed. To the residue were added water and 10 ¾ aqueous sodium hydroxide solution to make ρΗ = 8. K ether was extracted and dried on anhydrous sodium sulfate. The solvent was distilled off, and the residue was purified by silica gel column chromatography (dichloromethane: ethyl acetate = 20: 1) to obtain 2.52 g (47! «) Of colorless crystals of 2,2 '-(2, 3-dimethoxy). -1,4-phenylene) bis- (4,4-dimethyl-2-pizoline). The size of this paper applies to Chinese National Standard (CNS) Λ4 specification (2I0X297 mm) --------- ^ -Packing ------- Order ------ M-„--- 1 (Please read the precautions on the back before filling out this page) -55-Printed by the Economist Central Standards Bureau Shellfish Consumer Cooperative A7 B7 V. Description of the invention (5: j) Melting point 84.5-85. 5 t: Element Analyze MC1BH24N204. Calculated value: C, 65.04; Η, 7.28; N, 8.43. Found: C, 64.96; Η · 7.16; Ν, 8.41 Mass spectrum (m / Z): 3 32 (Μ +) Reference Example 33

將2,2'-(2,3-二甲氧基-1,4-伸苯基)雙- (4, 4-二甲基 -2-嗶唑啭)2.00g(6.02mm〇il )溶解於無水四氫呋喃20mA 中,一邊於冰冷下一邊歷3 0分鐘滴入溴化乙基鎂,0 . 9 2 Μ 四氫呋喃溶液16. 4mil (15. lmm〇Α )後,於室溫下授拌2小 時。於反應液中順次加入飽和氯化銨水溶液1 0 m Λ、水3 0 mil,並Μ醚萃取,Μ飽和食鹽水清洗後,於無水硫酸納 上乾燥。將溶劑餾除後,Μ矽膠柱層析(醋酸乙酯:己烷 =2:1)精製,取得1.988(100!«)無色梭晶之2,2’-(2,3-二 乙基-1,4-伸苯基)雙- (4,4-二甲基-2-喟唑啭&gt;。 熔點 49 . 0-50 . OTC 元素分析 MC2DH2BN20z 計算值:C, 73.14 ; Η * 8.59; Ν - 8.53 ----------裝------訂------嫁 (請先閱讀背面之注意事項再填寫本頁) 實測值:C, 72.97; Η .56 ; Ν .46 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210Χ 297公婕) 56 - A7 B7 五、發明説明(54) 質譜 (m/ 2 ) : 3 2 8 (M + 參考例342.00 g (6.02 mm) of 2,2 '-(2,3-dimethoxy-1,4-phenylene) bis- (4,4-dimethyl-2-benzolidine) was dissolved Ethylmagnesium bromide was added dropwise to the tetrahydrofuran 20mA under ice-cooling for 30 minutes, while the 0.92M tetrahydrofuran solution 16.4mil (15.1mm〇A) was added dropwise, followed by stirring at room temperature for 2 hours. . To the reaction solution were sequentially added a saturated ammonium chloride aqueous solution of 10 m Λ and water of 30 mil, and extracted with M ether. After being washed with M saturated brine, it was dried over anhydrous sodium sulfate. After the solvent was distilled off, the residue was purified by M silica gel column chromatography (ethyl acetate: hexane = 2: 1) to obtain 1.988 (100! «) Colorless spindle crystals of 2,2 '-(2,3-diethyl- 1,4-phenylene) bis- (4,4-dimethyl-2-oxazolyl) &gt; Melting point 49. 0-50. OTC Elemental analysis MC2DH2BN20z Calculated value: C, 73.14; 59 * 8.59; Ν -8.53 ---------- install ------ order ------ marry (please read the notes on the back before filling this page) Measured value: C, 72.97; Η .56 ; Ν .46 This paper size applies Chinese National Standard (CNS) Λ4 specification (210 × 297 gongjie) 56-A7 B7 V. Description of the invention (54) Mass spectrum (m / 2): 3 2 8 (M + Reference Example 34

Me MeMe Me

Me Me Γ Me Me ^Me Me Γ Me Me ^

Et Et 經濟部中央標準局員工消费合作杜印製 於2,2 ’-(2,3-二乙基-1,4-伸苯基)雙- (4, 4-二甲基-2-喟唑啭)1.86g(5.66min〇il )中加入硝基甲烷5.0mA與甲基 碘7.0mil (122mm〇il),並於801C下攪拌4小時。將反應液 注入醚30mA中,滤取析出之結晶,並經乙醇再結晶,取 得2.62g(763!)無色稜晶之2,2’-(2,3-二乙基-1,4-伸苯基) 雙- (3,4,4-三甲基-2 -噚唑啉鎰碘化物) 熔點 28 1 . 0-285 . Ot: 元素分析 MC22H34I2H20z 計算值:C, 43.15; Η, 5.60; N, 4.57 實測值:C,43.05; Η · 5.41 ; Ν,4.72 質譜 (m/Z):329(M++l-2MeI) 參考例35 令 OHC-Λν /&gt;- CHO Et El 本紙張疋度適用中國國家標準(CNS ) Λ4規格(2IOX297公釐) ----------&quot;-裝-------訂------派--i---- (請先閱讀背面之注意事項再填寫本頁) 57 經濟部中央標率局員工消资合作社印製 A 7 B7 五、發明説明(5:J) 將2,2'-(2,3-二乙基-1,4-伸笨基)雙-(3,4,4-三甲基 -2-喟唑啭鎰碘化物)2,45g(4.00mm〇il )懸浮於乙酵50mA 中,一邊於冰冷下一邊歷1小時滴下硼氫化納7 7 0 m s ( 2 0 . 4 in m 〇 A )後,於5它下攪拌3小時。於反應液中加入2 N鹽酸後 ,以醚萃取,並以飽和食鹽水清洗後於無水硫酸納上乾燥 。加人活性碳,並過滹,將溶劑餾除,取得102mg(13!U無 色稜晶之2,3 -二乙基-1,4 -苯羧基醛。 熔點 32.0-34.5 Ό 高分解能質譜 MC12H1402 計算值:190.0994 實測值:190.0990 實驗例1 H e L a細胞增殖抑制活性:Et Et Consumption cooperation between employees of the Central Bureau of Standards of the Ministry of Economic Affairs Du printed at 2,2 '-(2,3-diethyl-1,4-phenylene) bis- (4, 4-dimethyl-2- 喟To azole (1.86 g) (5.66 min), nitromethane 5.0 mA and methyl iodide 7.0 mil (122 mm) were added, and the mixture was stirred at 801 C for 4 hours. The reaction solution was poured into ether 30 mA, and the precipitated crystals were collected by filtration and recrystallized from ethanol to obtain 2.62 g (763!) Of colorless prisms of 2,2 '-(2,3-diethyl-1,4-elongation. Phenyl) bis- (3,4,4-trimethyl-2-oxazoline hydrazone iodide) Melting point 28 1. 0-285. Ot: Elemental analysis MC22H34I2H20z Calculated value: C, 43.15; Hf, 5.60; N , 4.57 Found: C, 43.05; Η · 5.41; Ν, 4.72 Mass spectrum (m / Z): 329 (M ++ l-2MeI) Reference Example 35 Let OHC-Λν / &gt;-CHO Et El The degree of paper Applicable to China National Standard (CNS) Λ4 specification (2IOX297 mm) ---------- &quot; -installation ------- order ------ pie--i ---- (Please read the notes on the back before filling out this page) 57 Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A 7 B7 V. Invention Description (5: J) will be 2,2 '-(2,3- 二Ethyl-1,4-benzyl) bis- (3,4,4-trimethyl-2-oxazolium iodide) 2,45 g (4.00 mm) was suspended in acetic acid 50 mA, one side Sodium borohydride (70.4 ms (20.4 in m OA)) was dripped over 1 hour under ice-cooling, and then stirred at 5 ° C for 3 hours. After adding 2 N hydrochloric acid to the reaction solution, it was extracted with ether, washed with saturated brine, and dried over anhydrous sodium sulfate. Add activated carbon, and dilute the solvent to obtain 102mg (13! U colorless prisms of 2,3-diethyl-1,4-benzenecarboxylaldehyde. Melting point 32.0-34.5 Ό High decomposition energy mass spectrometry MC12H1402 calculation Value: 190.0994 Found: 190.0990 Experimental Example 1 H e L a cell proliferation inhibitory activity:

HeLa S3细胞為在含有2mM麩胺酸、100ug/mil硫酸康納 徽素、105K非活化胎牛血清之依格耳最小培養基(Eagle's Minimal Medium,日水製藥(株),東京)中做為單層培着 基並於二氧化碳培養器內,維持在37t:。將1.8X103個 细胞播種至96孔口平板,並由次日開始令與受試化合物接 觸72小時。依Mosmann等人之方法(Mosmann, T., J. Imunol. Meth., 6f, 55-63, 1983),W 堪原 3-U,5 -二甲 基噻唑-2 -基]-2,5 -二苯基四唑溴化物(MTT)能力,測定化 合物處理培養後之活细胞數。相對於未處理细生長之化合 物處理细胞生長之比洌與化合物濃度之關係所算出之Μ 5 0 !&gt;;抑制濃度的细胞增殖抑制活性示於表1。_ 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公f ) -5 8 _ ----------装! (请先閱讀背面之注意事項蒋填寫本頁) 、va 五、發明説明(ίΚ;) A7 B7 實驗例2 對Colon26小鼠结腸癌之效果: 將IX 106個C〇l〇n26细胞移植至8通龄之CDFt小母鼠(日 本艾魯士(株),濱松)腋窩部之皮下,且腫瘤為Μ指觸而 確認之移植6日後由尾靜脈投予化合物1次。測定化合物投 予1週所摘出之腫癌重量,並由化合物投予群之平均腫瘤 重量(Τ)與對照群之平均腫瘤重量(C)之比(T/C)所得之腫 瘤增殖抑制率(TGI% = (1— T/C)x 100)做為抗腫瘤效果示 於表1。 尚,對於小鼠最大耐受量(Μ T D,m g / k g )與C ο 1 ο η 2 6小鼠 结腸癌之腫瘤增殖抑制率(TGI)為50¾之投予量(TGI5D, m g / k g )之比做為化學療法係數(Μ T D / T G 15。),並示於表1。 裝 - 、\''卩 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210Χ297公麓) 59 39-905S a? B7 五、發明説明(57) [表1 ] 經濟部中央標準局員工消费合作社印製 莨胞例編號 細胞增殖抑制 HeLaSa ICW (ng/ml) 抗腫瘤活性 Colon26 TGI% (μ g/kg) 化學療法係數 MTD/TGIbo 1 0.0031 , 92 (7.81) 21.9 3 '0.00934 ― 4 0.00276 91 (0.488) 9 5 . 0.00595 90 (1.95) — 6 0.0318 - ― 8 0.00158 89 (0.977) 4.6 10 0.011 85 (0.977) 7.4 13 0.0198 88 (3.91) 3.6 18 0.000459 丨 一 — 19 0.0134 — 20 0.0716 ― - 21 0.00035 ― — 22 0.0227 ― 由Μ上之結果,本發明化合物為顯示出優異的抗腫瘤活性。 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) I- In HI m I 1^1 - ί— — Vi I V..--1 n (請先聞讀背面之注意事項再填寫本頁) 訂 線 60 Λ7 B7五、發明説明(「θ) [發明之效果] 本發明化合物為具有優異的抗菌活性及抗腫瘤活性,且 對癌细胞選擇k高且為低毒性。本發明化合物由於被確認 有強的殺細胞活性及在廣泛的安全區下之抗腫瘤活性,故 不僅對於抗癌劑感受性低之腫癌亦為有效,且可期待減輕 癌患者化學療法之負擔。 I. I I I I !^衣 n I . I 1 訂 ' 1 I I !r', (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消费合作社印製 本紙張尺度適用中國國家標準(_ Λ侧训謂公绩) —HeLa S3 cells were prepared as single cells in Eagle's Minimal Medium (Nigsui Pharmaceutical Co., Ltd., Tokyo) containing 2 mM glutamic acid, 100 ug / mil Conamin sulfate, and 105 K non-activated fetal bovine serum. The layer was cultured in a carbon dioxide incubator and maintained at 37t :. 1.8X103 cells were seeded into a 96-well plate and contacted with the test compound for 72 hours from the next day. According to the method of Mosmann et al. (Mosmann, T., J. Imunol. Meth., 6f, 55-63, 1983), W Kanyuan 3-U, 5-dimethylthiazol-2-yl] -2,5 -Diphenyltetrazolium bromide (MTT) capability, which measures the number of viable cells after compound treatment and culture. The ratio of the growth of untreated fine-growth compound-treated cells to the ratio of the compound to the concentration of the compound was calculated as M 50. The inhibitory cell proliferation inhibitory activity is shown in Table 1. _ This paper size applies to China National Standard (CNS) Λ4 specification (210X 297 male f) -5 8 _ ---------- installed! (Please read the precautions on the back first to fill in this page), va 5. Description of the invention (ίΚ;) A7 B7 Experimental Example 2 Effect on Colon26 Mice Colon Cancer: IX 106 Collon 26 cells were transplanted to An 8-year-old female CDFt mouse (Ellus Co., Ltd., Hamamatsu, Japan) was subcutaneously in the axillary region and the tumor was confirmed by M finger touch. The compound was administered once through the tail vein 6 days after transplantation. The weight of tumors extracted from the compound administered for 1 week was measured, and the tumor proliferation inhibition rate obtained from the ratio (T / C) of the average tumor weight (T) of the compound administration group to the average tumor weight (C) of the control group ( TGI% = (1-T / C) x 100) is shown in Table 1 as the antitumor effect. Still, the maximum tolerated dose for mice (Μ TD, mg / kg) and the tumor growth inhibition rate (TGI) for colon cancer in mice of C ο 1 ο η 2 6 is 50 ¾ (TGI5D, mg / kg) The ratio of) is used as the chemotherapy coefficient (M TD / TG 15.) and is shown in Table 1. --\ '' 卩 (Please read the notes on the back before filling this page) Printed by the Central Consumers Bureau of the Ministry of Economic Affairs, Consumer Cooperatives This paper is printed in accordance with the Chinese National Standard (CNS) Λ4 specification (210 × 297 male feet) 59 39- 905S a? B7 V. Description of the invention (57) [Table 1] Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, No. of printed cells, cell proliferation inhibition, HeLaSa ICW (ng / ml), antitumor activity, Colon26 TGI% (μg / kg ) Chemotherapy coefficient MTD / TGIbo 1 0.0031, 92 (7.81) 21.9 3 '0.00934 ― 4 0.00276 91 (0.488) 9 5. 0.00595 90 (1.95) — 6 0.0318-― 8 0.00158 89 (0.977) 4.6 10 0.011 85 (0.977 ) 7.4 13 0.0198 88 (3.91) 3.6 18 0.000459 丨 — 19 0.0134 — 20 0.0716 — — 21 0.00035 — — 22 0.0227 — From the results of M, the compound of the present invention shows excellent antitumor activity. This paper size applies to Chinese National Standard (CNS) Λ4 specification (210X 297 mm) I- In HI m I 1 ^ 1-ί — Vi I V ..-- 1 n (Please read the precautions on the back before reading Fill in this page) Thread 60 Λ7 B7 V. Description of the invention ("θ) [Effect of the invention] The compound of the present invention has excellent antibacterial activity and antitumor activity, and has a high k and low toxicity to cancer cells. The present invention Since the compound has been confirmed to have strong cytocidal activity and anti-tumor activity in a wide range of safety areas, it is not only effective for tumors with low sensitivity to anticancer agents, but also expected to reduce the burden of chemotherapy on cancer patients. I. IIII! ^ 衣 n I. I 1 Order '1 II! R', (Please read the notes on the back before filling out this page) Printed by the Central Consumers Bureau of the Ministry of Economic Affairs, Consumer Cooperatives This paper is printed in accordance with Chinese national standards (_ Λ Side training means official performance) —

Claims (1)

399053 A8 B8 C8 D8 89. 4. 修正本 六、申請專利範圍 1. 一種如下式(1)所示之丙烯醯胺衍生物,其光學活性 體及其藥理容許鹽: ——-----------399053 A8 B8 C8 D8 89. 4. Amend this VI. Patent application scope 1. An acrylamide derivative represented by the following formula (1), its optically active substance and its pharmacologically acceptable salt: --------- ------ ⑴ (式中,X1及X2彼此獨立為氫原子、OR3 (R3為直鍵,或 分支狀Cj-Cs低烷基),或直鐽或分支低烷基;X1 及X2亦可彼此結合,而形成亞甲二氧基或者伸乙二氧基 ;環A為苯環、聯二笨環、聯吡啶環、萘環、憩環、藤醌 環或聯三苯環;R1及R2為彼此獨立為 R4。⑴ (wherein X1 and X2 are each independently a hydrogen atom, OR3 (R3 is a straight bond or a branched Cj-Cs lower alkyl group), or a straight 鐽 or branched lower alkyl group; X1 and X2 may also be combined with each other, and Forms methylene dioxy or ethylene dioxy; ring A is benzene ring, biphenyl ring, bipyridine ring, naphthalene ring, rest ring, rattanone ring or bitriphenyl ring; R1 and R2 are independent of each other as R4. (請先閱讀背面之注音?事項再填寫本頁) 裝---- · I I I I 線, 經濟部智慧財產局員工消費合作社印製 (R4為氫原子,Y為鹵原子 2x 為 Ηί〇Γ 或 (可Κ藉由1〜2個直鏈或分支狀Ci-C3低烷基•直踺或分支 狀(^-(:3低烷氧羰基、三鹵甲基,K進行取代)))。 2.—種如下式(3)所示之化合物的製造方法 i B \ 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1 399053 A8 B8 C8 D8 89. 4. 修正本 六、申請專利範圍 1. 一種如下式(1)所示之丙烯醯胺衍生物,其光學活性 體及其藥理容許鹽: ——-----------(Please read the note on the back? Matters before filling out this page.) Packing-· IIII line, printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs (R4 is a hydrogen atom, Y is a halogen atom 2x is Ηί〇Γ or ( It can be substituted by 1 or 2 straight-chain or branched Ci-C3 lower alkyl groups, or straight-chain or branched (^-(: 3 lower alkoxycarbonyl group, trihalomethyl group, K substituted))) 2. — A method for manufacturing a compound represented by the following formula (3) i B \ This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1 399053 A8 B8 C8 D8 89. 4. Amend this six, Patent application scope 1. An acrylamide derivative represented by the following formula (1), its optically active substance and its pharmacologically acceptable salt: --------------- ⑴ (式中,X1及X2彼此獨立為氫原子、OR3 (R3為直鍵,或 分支狀Cj-Cs低烷基),或直鐽或分支低烷基;X1 及X2亦可彼此結合,而形成亞甲二氧基或者伸乙二氧基 ;環A為苯環、聯二笨環、聯吡啶環、萘環、憩環、藤醌 環或聯三苯環;R1及R2為彼此獨立為 R4。⑴ (wherein X1 and X2 are each independently a hydrogen atom, OR3 (R3 is a straight bond or a branched Cj-Cs lower alkyl group), or a straight 鐽 or branched lower alkyl group; X1 and X2 may also be combined with each other, and Forms methylene dioxy or ethylene dioxy; ring A is benzene ring, biphenyl ring, bipyridine ring, naphthalene ring, rest ring, rattanone ring or bitriphenyl ring; R1 and R2 are independent of each other as R4. (請先閱讀背面之注音?事項再填寫本頁) 裝---- · I I I I 線, 經濟部智慧財產局員工消費合作社印製 (R4為氫原子,Y為鹵原子 2x 為 Ηί〇Γ 或 (可Κ藉由1〜2個直鏈或分支狀Ci-C3低烷基•直踺或分支 狀(^-(:3低烷氧羰基、三鹵甲基,K進行取代)))。 2.—種如下式(3)所示之化合物的製造方法 i B \ 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1 S99053六、申請專利範圍 A8 B8 C8 D8 (3) (式中 為(Please read the note on the back? Matters before filling out this page.) Packing-· IIII line, printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs (R4 is a hydrogen atom, Y is a halogen atom 2x is Ηί〇Γ or ( It can be substituted by 1 or 2 straight-chain or branched Ci-C3 lower alkyl groups, or straight-chain or branched (^-(: 3 lower alkoxycarbonyl group, trihalomethyl group, K substituted))) 2. —A method for manufacturing a compound represented by the following formula (3) i B \ This paper size is applicable to the Chinese National Standard (CNS) A4 (210 X 297 mm) 1 S99053 VI. Application scope A8 B8 C8 D8 (3) (Where (R4 ,Υ及(·?.![為同下述) 其特徵為將下式(2)所示之二羧酸衍生物 (2) 經濟部智慧財產局員工消費合作社印製 (式中,X1及X2為彼此獨立為氫原子、OR3 (R3為直鏈 或分支狀Ci-Ca低烷基),或直鏈或分支狀“-^^低烷基; X1及X2亦可彼此結合,而形成亞甲二氧基或伸乙二氧基 ;環A為苯環、聯二苯環、聯吡啶環、萘環、蒽環、葱酿 環或聯三苯環;R5為0H,或反應性殘基) K下式所示之化合物或其鹽:(R4, Υ, and (·?.! [Same as below) are characterized by printing the dicarboxylic acid derivative shown by the following formula (2) (2) printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs (where, X1 and X2 are each independently a hydrogen atom, OR3 (R3 is a linear or branched Ci-Ca lower alkyl group), or a linear or branched "-^^ low alkyl group; X1 and X2 may also be combined with each other, and Form methylenedioxy or ethylenedioxy; ring A is benzene ring, biphenyl ring, bipyridine ring, naphthalene ring, anthracene ring, onion ring or bitriphenyl ring; R5 is 0H, or reactive Residue) K a compound represented by the formula or a salt thereof: (R4為氫原子、Y為鹵原子; 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ^------------ ^--------訂---------線. (請先閱讀背面之注音2事項再填寫本頁) 389053 g D8 六、申請專利範圍(R4 is a hydrogen atom and Y is a halogen atom; this paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) ^ ------------ ^ ------ --Order --------- line. (Please read the note 2 on the back before filling out this page) 389053 g D8 6. Scope of patent application (可Μ藉由1〜2個直鰱或分支狀(^-(: 3低烷基、直鏈或分支 狀(^-(:3低烷氧羰基、三鹵甲基,Μ進行取代))予Μ醯化)。 .--I I--訂--I--- --- (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 3 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐)(M can be substituted by 1 ~ 2 straight or branched (^-(: 3 lower alkyl, linear or branched (^-(: 3 lower alkoxycarbonyl, trihalomethyl, M substituted)) (I will be M). .-- I I--Order --I --- --- (Please read the notes on the back before filling this page) Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economy 3 paper sizes Applicable to China National Standard (CNS) A4 (210 X 297 mm)
TW085100362A 1994-11-29 1996-01-11 Acrylamide derivatives and process for the preparation TW399053B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29527494 1994-11-29
JP30585195A JP3759772B2 (en) 1994-11-29 1995-11-24 Acrylamide derivative and method for producing the same

Publications (1)

Publication Number Publication Date
TW399053B true TW399053B (en) 2000-07-21

Family

ID=26560190

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085100362A TW399053B (en) 1994-11-29 1996-01-11 Acrylamide derivatives and process for the preparation

Country Status (2)

Country Link
JP (1) JP3759772B2 (en)
TW (1) TW399053B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0103304A3 (en) * 1998-01-28 2002-10-28 Shionogi & Co Novel tricyclic compounds and pharmaceutical compositions thereof
JP2009526778A (en) * 2006-02-13 2009-07-23 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ Bis-pyrrolo [2,1-c] [1,4] benzodiazepine-anthraquinone conjugate as antitumor agent and method for producing the same

Also Published As

Publication number Publication date
JPH08208653A (en) 1996-08-13
JP3759772B2 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
KR100408909B1 (en) Novel peptide derivatives
JPH02111772A (en) Beta-carboxylinic acid, benzofrane analogue and benzothiophene analogue and pharmaceutically acceptable acid addition salts thereof, and production thereof, composition having static cell characteristics and treatment of tumor
CS265248B2 (en) Process for preparing analogs of rebeccamycine
EP4289843A1 (en) Pyridopyrimidinone derivative, preparation method therefor, and use thereof
EP2020410B1 (en) Pyrido[2,3-d]pyrimidine derivatives, process for their preparation and their therapeutical use
CA3023444A1 (en) Antimicrobials and methods of making and using same
WO1995005374A1 (en) Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity
EP2021334B1 (en) Synthesis and uses of pyroglutamic acid derivatives
WO2023041055A1 (en) Kif18a inhibitor
JP4081148B2 (en) Anthracycline derivatives
TW399053B (en) Acrylamide derivatives and process for the preparation
JPH06508146A (en) Carbocyclic and heterocyclic HIV protease inhibitors
FR2758329A1 (en) New imidazole-4-butane-boronic acid derivatives
JPH08176124A (en) New antitumor compound
EP1101765B1 (en) Camptothecin analogues, process for their preparation and pharmaceutical compositions containing them
JP2004502773A (en) Variolin derivatives as anticancer agents
CN115677828A (en) Antitumor m-dichlorophenol derivative and preparation method thereof
JP7247144B2 (en) Dihydrochromene derivative
US9873707B2 (en) Methods and intermediates for preparing macrolactams
WO2001034566A2 (en) Protease inhibitors
JPH08509740A (en) Water-soluble derivative of camptothecin
Formánek et al. Synthesis and migrastatic activity of cytochalasin analogues lacking a macrocyclic moiety
US5248692A (en) DC-89 derivatives as anti-tumor agents
WO1997004783A2 (en) Bis-1-oxaquinolizidine alkaloids from a marine sponge with antitumor activity
US6869971B1 (en) UCS1025 derivatives

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MK4A Expiration of patent term of an invention patent